
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5332BE8AF277C30532BE00049A7F2C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="sportsmedo">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Sports Medicine - Open">
<meta name="citation_title" content="The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial">
<meta name="citation_author" content="Ayshe Sahinovic">
<meta name="citation_author_institution" content="Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia">
<meta name="citation_author_institution" content="School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Namson S Lau">
<meta name="citation_author_institution" content="The Boden Initiative, Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Central Clinical School, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Angelo Sabag">
<meta name="citation_author_institution" content="Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Rebecca Gordon">
<meta name="citation_author_institution" content="Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia">
<meta name="citation_author_institution" content="School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Amanda J Cox">
<meta name="citation_author_institution" content="School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD Australia">
<meta name="citation_author" content="Katie Walker">
<meta name="citation_author_institution" content="Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia">
<meta name="citation_author_institution" content="School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Christopher Irwin">
<meta name="citation_author_institution" content="School of Allied Health, Sport and Social Work, Griffith University, Gold Coast, QLD Australia">
<meta name="citation_author" content="Ben Desbrow">
<meta name="citation_author_institution" content="School of Allied Health, Sport and Social Work, Griffith University, Gold Coast, QLD Australia">
<meta name="citation_author" content="Nathan Johnson">
<meta name="citation_author_institution" content="Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Paul J Austin">
<meta name="citation_author_institution" content="School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Paul Haber">
<meta name="citation_author_institution" content="Central Clinical School, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Iain S McGregor">
<meta name="citation_author_institution" content="Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia">
<meta name="citation_author_institution" content="School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author" content="Danielle McCartney">
<meta name="citation_author_institution" content="Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia">
<meta name="citation_author_institution" content="School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_author_institution" content="Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="96">
<meta name="citation_doi" content="10.1186/s40798-025-00895-w">
<meta name="citation_pmid" content="40839290">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/pdf/40798_2025_Article_895.pdf">
<meta name="description" content="Athletes report using cannabidiol (CBD), a non-intoxicating constituent of Cannabis sativa L., to enhance post-exercise recovery and manage other health conditions (e.g., poor sleep, anxiety, concussion). However, whether CBD influences ...">
<meta name="og:title" content="The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Athletes report using cannabidiol (CBD), a non-intoxicating constituent of Cannabis sativa L., to enhance post-exercise recovery and manage other health conditions (e.g., poor sleep, anxiety, concussion). However, whether CBD influences ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370602">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40798-025-00895-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40798_2025_Article_895.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370602%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370602/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370602/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-sportsmedo.gif" alt="Sports Medicine - Open logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Sports Medicine - Open" title="Link to Sports Medicine - Open" shape="default" href="http://www.springer.com/medicine/journal/40798" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sports Med Open</button></div>. 2025 Aug 21;11:96. doi: <a href="https://doi.org/10.1186/s40798-025-00895-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40798-025-00895-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sports%20Med%20Open%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sports%20Med%20Open%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sports%20Med%20Open%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sports%20Med%20Open%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The Acute Effects of Cannabidiol on Physiological and Subjective Responses to Endurance Exercise: A Dose-Ranging Randomised Controlled Crossover Trial</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sahinovic%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ayshe Sahinovic</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ayshe Sahinovic</span></h3>
<div class="p">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div class="p">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>4</sup>Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sahinovic%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ayshe Sahinovic</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lau%20NS%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Namson S Lau</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Namson S Lau</span></h3>
<div class="p">
<sup>5</sup>The Boden Initiative, Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>6</sup>Central Clinical School, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lau%20NS%22%5BAuthor%5D" class="usa-link"><span class="name western">Namson S Lau</span></a>
</div>
</div>
<sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabag%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Angelo Sabag</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Angelo Sabag</span></h3>
<div class="p">
<sup>4</sup>Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>7</sup>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sabag%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Angelo Sabag</span></a>
</div>
</div>
<sup>4,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gordon%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Rebecca Gordon</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Rebecca Gordon</span></h3>
<div class="p">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div class="p">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gordon%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebecca Gordon</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cox%20AJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Amanda J Cox</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Amanda J Cox</span></h3>
<div class="p">
<sup>8</sup>School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cox%20AJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Amanda J Cox</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Walker%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Katie Walker</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Katie Walker</span></h3>
<div class="p">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div class="p">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Walker%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Katie Walker</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Irwin%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Christopher Irwin</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Christopher Irwin</span></h3>
<div class="p">
<sup>9</sup>School of Allied Health, Sport and Social Work, Griffith University, Gold Coast, QLD Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Irwin%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher Irwin</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Desbrow%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Ben Desbrow</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Ben Desbrow</span></h3>
<div class="p">
<sup>9</sup>School of Allied Health, Sport and Social Work, Griffith University, Gold Coast, QLD Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Desbrow%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Ben Desbrow</span></a>
</div>
</div>
<sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Johnson%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Nathan Johnson</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Nathan Johnson</span></h3>
<div class="p">
<sup>4</sup>Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>7</sup>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Johnson%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nathan Johnson</span></a>
</div>
</div>
<sup>4,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Austin%20PJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Paul J Austin</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Paul J Austin</span></h3>
<div class="p">
<sup>10</sup>School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Austin%20PJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Paul J Austin</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haber%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Paul Haber</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Paul Haber</span></h3>
<div class="p">
<sup>6</sup>Central Clinical School, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Haber%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paul Haber</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGregor%20IS%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Iain S McGregor</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Iain S McGregor</span></h3>
<div class="p">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div class="p">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McGregor%20IS%22%5BAuthor%5D" class="usa-link"><span class="name western">Iain S McGregor</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCartney%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Danielle McCartney</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Danielle McCartney</span></h3>
<div class="p">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div class="p">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">
<sup>4</sup>Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCartney%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Danielle McCartney</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff2">
<sup>2</sup>Brain and Mind Centre, The University of Sydney, 94 Mallett Street, Camperdown, Sydney, NSW 2050 Australia </div>
<div id="Aff3">
<sup>3</sup>School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff4">
<sup>4</sup>Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff5">
<sup>5</sup>The Boden Initiative, Charles Perkins Centre, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff6">
<sup>6</sup>Central Clinical School, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff7">
<sup>7</sup>Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia </div>
<div id="Aff8">
<sup>8</sup>School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD Australia </div>
<div id="Aff9">
<sup>9</sup>School of Allied Health, Sport and Social Work, Griffith University, Gold Coast, QLD Australia </div>
<div id="Aff10">
<sup>10</sup>School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW Australia </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 30; Accepted 2025 Jul 13; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370602  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40839290/" class="usa-link">40839290</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Athletes report using cannabidiol (CBD), a non-intoxicating constituent of <em>Cannabis sativa</em> L., to enhance post-exercise recovery and manage other health conditions (e.g., poor sleep, anxiety, concussion). However, whether CBD influences performance-related outcomes remains unclear. This study investigated the acute effects of a low, nutraceutical (50 mg) and moderate, therapeutic (300 mg) dose of CBD on physiological and subjective responses to endurance exercise in trained runners.</p></section><section id="sec2"><h3 class="pmc_sec_title">Results</h3>
<p id="Par2">A randomised double-blind, placebo-controlled, crossover clinical trial was conducted at the University of Sydney between 24th October 2022 and 4th March 2024. Twenty-five participants (16 male; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq1"><math id="d33e319"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub> = 53.1 ± 7.5 mL·min kg<sup>−1</sup>) received either 0 (placebo), 50 or 300 mg CBD 1.5 h prior to completing a 60-min, submaximal intensity (~ 70% <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq2"><math id="d33e334"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>) treadmill run (RUN 1), followed by an incremental run to volitional exhaustion (RUN 2). Neither dose of CBD altered subjective responses (i.e., affective valence, enjoyment, perceived exertion, pain) during RUN 1, nor enjoyment, mood or anxiety following RUN 1 and 2 (<em>p</em>’s &gt; 0.05). CBD also had a limited effect on exercise physiology and performance, with heart rate, exercise efficiency (i.e., <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq3"><math id="d33e351"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>), <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq4"><math id="d33e364"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub> and time to exhaustion (TTE) unchanged relative to placebo (<em>p</em>’s &gt; 0.05). However, 300 mg CBD decreased the respiratory exchange ratio during RUN 1 (<em>p</em> = 0.030) and 50 mg CBD increased blood glucose upon cessation of RUN 2 <em>(p</em> = 0.003), compared to placebo. There was no effect of either dose on plasma concentrations of muscle damage markers, creatine and myoglobin (<em>p</em>’s &gt; 0.05), but a Treatment x Time x Sex interaction was identified for the gastrointestinal barrier function marker, lipopolysaccharide, with post hoc analyses revealing higher concentrations in females Post RUN 2 on 50 mg (<em>p</em> = 0.032), but not 300mg CBD (<em>p</em> = 1.000), compared to placebo.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par3">CBD (50 mg, 300 mg; acute) does not appear to alter the subjective experience of submaximal intensity exercise, impact endurance performance (i.e., TTE) or have compelling effects on physiological responses to exercise. Use of CBD by athletes is, therefore, unlikely to be ergolytic or ergogenic at low to moderate doses.</p></section><section id="sec4"><h3 class="pmc_sec_title">Trial registration</h3>
<p id="Par4">The trial was approved by the Sydney Local Health District’s Human Research Ethics Committee (2021/ <a href="https://www.ncbi.nlm.nih.gov/protein/ETH11945" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ETH11945</a>; X21-0392) and registered prospectively with the Australia and New Zealand Clinical Trials Registry (ACTRN12622000717752).</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s40798-025-00895-w.</p></section></section><section class="abstract" id="Abs2"><h2>Key points</h2>
<ul class="list" style="list-style-type:disc">
<li><p id="Par600">In this randomised, double-blind, placebo-controlled, crossover trial of 25 trained runners, neither 50 mg nor 300 mg of CBD influenced affective valence, exercise enjoyment, perceived exertion or pain during submaximal intensity running.</p></li>
<li><p id="Par700">CBD had a minimal impact on physiological responses to submaximal and maximal intensity running and did not enhance or impair endurance performance.</p></li>
<li><p id="Par800">This suggests that low to moderate doses of CBD are unlikely to be ergogenic or ergolytic in trained athletes.</p></li>
</ul>
<section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s40798-025-00895-w.</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par67">Cannabidiol (CBD) is one of over 140 terpenophenolic compounds, collectively termed ‘phytocannabinoids’, that are found within <em>Cannabis sativa</em> L. [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Unlike the principal phytocannabinoid, Δ<sup>9</sup>-tetrahydrocannabinol (THC), CBD does not induce the sedation, euphoria or cognitive and psychomotor impairment typically associated with cannabis use [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. It does, however, interact with a diverse suite of pharmacological targets and possesses considerable therapeutic potential [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. CBD has demonstrated efficacy in treating seizures associated with rare forms of paediatric epilepsy [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>] and is currently approved by the Food and Drug Administration (FDA) for this indication (under the brand name ‘Epidiolex®’) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. CBD has also demonstrated anxiolytic effects in recent clinical trials [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], as well as anti-inflammatory, neuroprotective, and analgesic effects in preclinical studies [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. These therapeutic effects are typically observed with oral (or human equivalent oral) doses between ~ 300–1500 mg [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>] and are of increasing interest to various clinical and non-clinical populations [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<p id="Par68">Athletes, in particular, have taken an interest in CBD as a means to facilitate recovery and manage health conditions [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Twenty-six percent (26%) of professional rugby players surveyed in a recent study (<em>n</em> = 517), reported either currently using or having previously used CBD [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The most common reasons for use were to enhance recovery (80%), improve sleep (78%), reduce anxiety (32%), and for “other” medical purposes (14%; e.g., managing concussion). The use of CBD among professional athletes has been facilitated by its removal from the World Anti-Doping Agency’s (WADA) Prohibited List in 2018 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] and increased commercial availability [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. While most athletes are ineligible to access registered CBD medicines (e.g., Epidiolex®), a wide range of unregistered products (‘nutraceuticals’) containing lower doses of CBD (e.g., ~ 10–150 mg·mL<sup>−1</sup>) have become readily accessible online and over-the-counter in many countries (i.e., USA, UK, EU) [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<p id="Par69">Despite its widespread use, research on the topic of CBD in the context of sport and exercise remains limited. Most studies conducted to date have investigated the effects of CBD on post-exercise recovery, yielding unclear results [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. An improved understanding of CBD’s effects on performance related outcomes, as well as physiological and subjective responses to exercise, is required to determine its utility within the sporting context and inform the ongoing evaluation of its status on WADA’s Prohibited List.</p>
<p id="Par70">Accordingly, in 2020, our research team conducted a pilot randomised controlled trial investigating the acute effects of CBD on responses to endurance exercise [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. In this exploratory study, nine endurance-trained males (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq13"><math id="d33e874"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>: 57.4 mL·kg·min<sup>−1</sup>) received 300 mg CBD or placebo, in a double-blind, crossover design, 1.5 h prior to completing a submaximal intensity treadmill run (60 min; ~ 70% <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq14"><math id="d33e889"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>) followed by an incremental run to exhaustion. Although this pilot study was not formally powered to detect significance, CBD demonstrated some effects that were deemed worthy of further investigation.</p>
<p id="Par71">First, and perhaps most notably, CBD appeared to increase positive feelings (i.e., affect) during submaximal intensity exercise. This observation is noteworthy as mood and affective states have been demonstrated to influence performance across various modalities [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>–<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Exercise enjoyment may also be a mediating factor for adherence (i.e. to training, exercise interventions) [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>] as greater enjoyment has been demonstrated to increase the likelihood of performing exercise [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Second, CBD appeared to increase submaximal (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq15"><math id="d33e921"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>) and peak (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq16"><math id="d33e934"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>) rates of oxygen consumption. These measures are important physiological determinants of endurance performance [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]; however, no overt difference in time to exhaustion (TTE) was observed. Given the pilot study was conducted in a small sample of male athletes, further research investigating the effects of CBD on responses to exercise is warranted.</p>
<p id="Par72">The aim of the present study was to investigate the effects of CBD on physiological and subjective responses to exercise in a larger sample of male and female athletes. Two acute doses of CBD were investigated—one that has previously demonstrated therapeutic potential (300 mg) (e.g., in treating situational anxiety and other conditions [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]) and a lower dose (50 mg) that more closely resembles those available to athletes [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. It was hypothesised that CBD would: (1) increase positive affect during submaximal exercise, and (2) have only subtle effects on physiological responses to exercise that do not affect endurance performance.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study Design</h3>
<p id="Par73">A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial was conducted at the Charles Perkins Centre—Royal Prince Alfred Hospital Clinic (Sydney, Australia) in accordance with the standards of ethics outlined in the Declaration of Helsinki (1983). The trial was approved by the Sydney Local Health District’s Human Research Ethics Committee (2021/<a href="https://www.ncbi.nlm.nih.gov/protein/ETH11945" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ETH11945</a>; X21-0392) and registered prospectively with the Australia and New Zealand Clinical Trials Registry (ACTRN12622000717752).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Participants</h3>
<p id="Par74">Healthy males and females who: (1) were aged between 18 and 45 years; (2) reported running an average of ≥ 40 km wk<sup>−1</sup>; and (3) had not used cannabis and/or cannabinoids in the last three months were recruited. Full eligibility criteria, including exclusion criteria, are available in Supplementary File 1.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Screening Procedure</h3>
<p id="Par75">Volunteers completed an online questionnaire and a telephone interview. Those suitable to continue subsequently attended an in-person screen where they were informed of the experimental procedures before providing written informed consent and being assessed for eligibility by the trial coordinator (A.S.) and trial physician (N.L.).</p>
<p id="Par76">Eligible participants then provided basic demographic information, including anthropometric measures (i.e., height, weight, body composition (BC-418; Tanita®, Tokyo, Japan)), and performed a modified Balke treadmill test [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>] to assess their <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq17"><math id="d33e982"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>. The test was completed at a fixed speed (10 km·h<sup>−1</sup>) and an initial gradient of 0%; the gradient then increased by 2% every 3 min until participants reached volitional exhaustion. Participants received feedback and encouragement to ensure they attained maximal exertion. Respiratory gases were sampled continuously throughout the test. The average rate of oxygen consumption (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq18"><math id="d33e997"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>) over the final 30 s of each completed increment was also calculated, and the linear relationship between <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq19"><math id="d33e1011"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> and treadmill gradient determined, to set the exercise intensity during treatment sessions [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq20"><math id="d33e1027"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub> was taken as the highest average <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq21"><math id="d33e1041"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> attained over a 30 s period.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Randomisation</h3>
<p id="Par77">Participants were randomised to one of six possible treatment orders, together comprising a balanced Latin Square, in a 1:1:1:1:1:1 ratio using a pre-populated randomisation schedule. The schedule was randomly generated in four balanced blocks of six (and one ‘block’ of one) by an independent researcher using an online random number generator (<a href="http://www.sealedenvelope.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.sealedenvelope.com</a>).</p>
<p id="Par78">Each treatment order was linked to a unique identification code and these codes were assigned to participants in a sequential order at the beginning of their first treatment session.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Blinding</h3>
<p id="Par79">Only the aforementioned researcher, a second independent researcher, and the pharmacists dispensing the treatments could access the randomisation schedule. None of these individuals had contact with participants or further involvement in the trial.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Treatments</h3>
<p id="Par80">The investigational product (MediCabilis™ 100 CBD Isolate; BOD Australia Ltd, Sydney, Australia) was an oral formulation of plant-derived CBD (100 mg·mL<sup>−1</sup>) in medium chain triglyceride (MCT) oil. It contained &lt; 0.01 mg·mL<sup>−1</sup> THC and no other minor cannabinoids or terpenes. The placebo was an equivalent volume of MCT oil only. Both treatments were manufactured at GMP-licenced facilities and stored at the RPAH Pharmacy.</p>
<p id="Par81">Pharmacists dispensed 3.0 mL of oil providing either 0, 50 or 300 mg CBD (Placebo; CBD50; CBD300) into two oral syringes (i.e., 0.5 mL in one and 2.5 mL in the other). The syringes were amber in colour and carried no treatment identifying information.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Experimental Procedures</h3>
<p id="Par82">Each participant completed three treatment sessions (i.e., one session per dose), with each session separated by a washout period ≥ 7 days. Participants were instructed to maintain their usual diet and exercise patterns and avoid using cannabis, cannabinoids and illicit drugs throughout their involvement in the trial.</p>
<section id="Sec10"><h4 class="pmc_sec_title">Standardisation Procedures</h4>
<p id="Par83">Prior to each session, participants were instructed to: (1) avoid anti-inflammatory medication (&gt; 4 days), alcohol (&gt; 24 h), moderate to strenuous exercise (&gt; 24 h), caffeine (&gt; 12 h) and foods that may affect CBD metabolism (i.e., grapefruit and Seville oranges) (&gt; 12 h); (2) keep a record of all foods and fluids consumed (24 h); (3) consume a pre-packaged standardised evening meal (~ 60 kJ·kg<sup>−1</sup>); (4) fast overnight (~ 10 h); (5) spend ≥ 8 h in bed, (6) collect a first-morning urine sample; and (7) consume 500 mL of water before arriving at the laboratory. Individuals received a copy of their diet record from the first treatment session and were instructed to replicate their dietary intake before each subsequent session.</p></section><section id="Sec11"><h4 class="pmc_sec_title">Treatment Sessions</h4>
<p id="Par84">Participants arrived at the laboratory in a fasted state between 07:00 and 08:30 am, with arrival times replicated across sessions to avoid diurnal variation. Upon arrival, participants were asked to verbally acknowledge compliance with the standardisation procedures, prior to completing a urine drug screen (UDS) to verify cannabis abstinence (Drug Check ® NxStep OnSite Urine Drug Test) and a urine pregnancy test, if applicable (Alere ™ hCG Combo Cassette). Participants’ first-morning urine samples were also analysed to assess hydration status (Urine Specific Gravity [USG]; Palette Digital Refractometer, ATAGO, USA). If USG was &gt; 1.024, likely indicating hypohydration [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>] a second on-site sample was collected and analysed (note: all specimens were &lt; 1.024).</p>
<p id="Par85">The remainder of the test session was divided into seven blocks: Baseline (pre-treatment), Pre RUN 1 (60–90 min post treatment), RUN 1 (90–150 min), Post RUN 1 (150–170 min), RUN 2 (180–~ 200 min), Post RUN 2 (~ 200–220 min) and 1h Post RUN 2 (~ 260–280 min). The specific assessments completed during each block are summarised in Fig. <a href="#Fig1" class="usa-link">1</a> and detailed below (see ‘Primary Outcome’ and ‘Secondary Outcomes’).</p>
<figure class="fig xbox font-sm" id="Fig1"><h5 class="obj_head">Fig. 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/343b44bb69de/40798_2025_895_Fig1_HTML.jpg" loading="lazy" id="MO1" height="311" width="774" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A timeline of the experimental sessions. AE: adverse events; BG: blood glucose; BL: blood lactate; BP: blood pressure; FS: Feelings Scale; GI: Gastrointestinal; hCG: human chorionic gonadotrophin pregnancy test; HR: heart rate; POMS: Profile of Mood States; RPE: Rating of Perceived Exertion; RUN 1: 60-min run at a fixed submaximal intensity (~ 70% <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq68"><math id="d33e1106"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O2max); RUN 2: Incremental run to volitional exhaustion; S-PACES: Short-form Physical Activity Enjoyment Scale; STAI-S: Short-form State Trait Anxiety Inventory; TTE: time to exhaustion; UDS: urine drug screen; USG: urine specific gravity. Note: Arrival time is approximate</p></figcaption></figure><p id="Par86">Following the Baseline assessments, participants received a standardised breakfast meal consisting of two slices of raisin toast (TipTop® Café Style Thick Cut) and up to 30 g of jam (Cottee’s®), 20 g of margarine (Flora® Proactive Original) and up to 500 mL water, consumed ad libitum during the first session, with individual intakes recorded and replicated across subsequent sessions. Nutritional values were calculated based on the information panel provided on the packaging of each item. Treatments were then self-administered (via oral ingestion), immediately following the consumption of a high-strength mint (Fisherman’s Friend®) intended to mask any flavour differences [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Participants were observed during this period to verify compliance.</p>
<p id="Par87">Exercise testing was initiated 1.5 h after treatment administration and performed on a motorised treadmill (Trackmaster® TMX428CP) as described below. Participants were not permitted to consume fluid during exercise but received up to 500 mL of water on completion of the Post RUN 1 and 2 assessments, with individual intakes recorded and replicated across sessions.</p>
<p id="Par88">At the end of each treatment session, participants completed an adverse event (AE) checklist and indicated which treatment they thought they had received and their confidence in this guess on a 4-point Likert scale (1 = ‘not at all’ to 4 = ’extremely’).</p></section><section id="Sec12"><h4 class="pmc_sec_title">Submaximal Exercise (RUN 1)</h4>
<p id="Par89">Participants ran for 60 min at a fixed speed (10 km·h<sup>−1</sup>) and individualised gradient designed to elicit an intensity of ~ 70% <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq22"><math id="d33e1134"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max.</sub> There was no communication between the participant and researcher/s throughout this time, except to facilitate data collection. Measures were collected at precisely the same time across sessions to minimise any influence of metabolic drift [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>].</p></section><section id="Sec13"><h4 class="pmc_sec_title">Incremental Exercise (RUN 2)</h4>
<p id="Par90">Thirty minutes after cessation of RUN 1, participants performed an incremental test to volitional exhaustion. The treadmill was set at a fixed speed (10 km·h<sup>−1</sup>) and an initial gradient of 0%; the gradient then increased by 2% every 3 min until volitional exhaustion. Participants did not receive information on elapsed time or encouragement during the test.</p></section></section><section id="Sec14"><h3 class="pmc_sec_title">Data Collection</h3>
<section id="Sec15"><h4 class="pmc_sec_title">Primary Outcome</h4>
<p id="Par91">Affective valence was assessed at 20-min intervals throughout RUN 1 using the 11-point Feelings Scale (FS) [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>], where – 5 = “feeling very bad” and + 5 = “feeling very good”. Participants were instructed to rate the emotional component of their experience, only<em>.</em></p></section><section id="Sec16"><h4 class="pmc_sec_title">Secondary Outcomes</h4>
<p id="Par92">A brief summary of methods is summarised below. Detailed methods of each secondary outcome can be found in Supplementary File 1.</p>
<section id="Sec17"><h5 class="pmc_sec_title">Intra-Exercise Measures</h5>
<p id="Par93">The following were measured at 20-min intervals throughout RUN 1:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par94"><strong>Heart rate (HR)</strong> using a chest-strap monitor (Polar H10 HR Sensor, Polar Electro, Finland).</p></li>
<li><p id="Par95"><strong>Exercise enjoyment</strong> using the short-form (8-item) Physical Activity Enjoyment Scale (PACES) (score range 8–54), where higher scores represent greater enjoyment [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p></li>
<li><p id="Par96"><strong>Ratings of perceived exertion (RPE)</strong> using the 15-point Borg Scale, where 6 = “no exertion” and 20 = “maximal exertion” [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>].</p></li>
<li><p id="Par97"><strong>Whole body pain</strong> using a 100 mm visual analog scale (VAS), where 0 = “no pain” and 100 = “extreme pain”.</p></li>
</ul>
<p id="Par98">The following were measured upon completion of RUN 1 and RUN 2:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par99"><strong>Capillary blood glucose</strong> concentration (AccuCheck ® Performa, Roche, Switzerland).</p></li>
<li><p id="Par100"><strong>Capillary blood lactate</strong> concentration (Lactate Scout 4, EKF Diagnostics, United Kingdom).</p></li>
</ul>
<p id="Par101">The following were measured at the point of cessation of RUN 2:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par102"><strong>Peak HR</strong></p></li>
<li><p id="Par103"><strong>Time to exhaustion (TTE)</strong></p></li>
</ul></section><section id="Sec18"><h5 class="pmc_sec_title">Metabolic and Respiratory Outcomes</h5>
<p id="Par104">Expired respiratory breath-by-breath measurements of <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq23"><math id="d33e1230"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>, expired CO<sub>2</sub> (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq24"><math id="d33e1245"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>), respiratory exchange ratio (RER), respiratory rate (RR), tidal volume (V<sub>T</sub>) and minute ventilation (<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq25"><math id="d33e1261"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>E</sub>) were collected using an Ultima PFX® pulmonary function system (MGC Diagnostics®) with a PreVent™ flow pneumotach (MCG Diagnostics®) and mouthpiece. RUN 1 measures were collected between 24–32, 37–45 and 50–58 min and averaged across each collection period prior to analysis. RUN 2 measures were collected after the participant’s HR reached 90% HR<sub>max</sub>. <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq26"><math id="d33e1275"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub> was taken as the highest average <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq27"><math id="d33e1289"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> attained over 30 s; all other peak respiratory outcomes were taken as the average during the aforementioned period.</p>
<p id="Par105">Rates of carbohydrate (CHOox) and fat oxidation (FATox), as well as total energy expenditure (EE) during RUN 1 were calculated using the equations of Frayn [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>], assuming negligible protein oxidation and energy equivalents of 16.75 kJ·g<sup>−1</sup> of carbohydrate and 37.68 kJ·g<sup>−1</sup> of fat.</p></section><section id="Sec19"><h5 class="pmc_sec_title">Inter-exercise Measures</h5>
<p id="Par106">The following were measured Pre- and Post RUN 1 and Post RUN 2:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par107"><strong>Exercise enjoyment</strong> using the long-form (18-item) PACES [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>] (score range: 18–126), where higher scores represent greater enjoyment. Participants were told that their Pre RUN 1 responses should reflect their attitude toward running in general.</p></li>
<li><p id="Par108"><strong>Nude body mass</strong> (BC-418; Tanita®, Tokyo, Japan) to estimate sweat loss. Water intake and urinary losses were also measured and factored into these estimations.</p></li>
</ul>
<p id="Par109">The following were measured at Baseline, Pre- and Post RUN 1, Post RUN 2 and 1 h Post RUN 2:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par110"><strong>State anxiety</strong> using the short-form (6-item) State-Trait Anxiety Inventory (STAI-S) [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>] (score range 6 –24), where higher values represent higher anxiety.</p></li>
<li><p id="Par111"><strong>Mood</strong> (i.e., ‘Tension’, ‘Depression’, ‘Fatigue’, ‘Confusion’, ‘Anger’, ‘Vigour’, ‘Esteem’, ‘Total Mood Disturbance’) using the short-form (41-item) Profile of Mood States (POMS) [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>], <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a> (score range 0–28), where higher values represent stronger feelings.</p></li>
<li><p id="Par112"><strong>Gastrointestinal comfort</strong> (i.e., ‘Abdominal Pain’, ‘Nausea’, ‘Heartburn’, ‘Regurgitation’, ‘Belching’, ‘Bloating’, ‘Flatulence’) using a 100 mm VAS, where 0 = “not at all” and 100 = “extremely “for each item.</p></li>
<li><p id="Par113"><strong>Plasma cannabinoid</strong> concentrations using ultra-high performance liquid chromatography-tandem mass spectrometry and previously validated methods [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>].</p></li>
<li><p id="Par114"><strong>Serum lipopolysaccharide (LPS)</strong> concentrations using the limulus amebocyte lysate (LAL) chromogenic endpoint assay.</p></li>
<li><p id="Par115"><strong>Serum myoglobin (Myo) and creatine kinase (CK)</strong> concentrations using commercially available enzyme-linked immunosorbent assay (ELISA) kits.</p></li>
</ul>
<p id="Par116">The following were measured remotely the morning following each treatment session:</p>
<ul class="list" style="list-style-type:disc">
<li><p id="Par117"><strong>Sleep quality</strong> using an 11-point scale, where –5 = “very poor” and + 5 = “very good”</p></li>
<li><p id="Par118"><strong>Muscle soreness</strong> using an 11-point scale, where 1 = “no soreness” and + 10 = “extreme soreness”.</p></li>
</ul>
<p id="Par119">Seated HR and blood pressure (BP) were also measured at Baseline, Pre- and Post RUN 1 and Post RUN 2 using an automated sphygmomanometer (OMRON®, M2 Basic). Measurements were taken in duplicate, or triplicate if systolic BP values differed by &gt; 15 mmHg, and averaged prior to analysis [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>].</p></section></section></section><section id="Sec20"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p id="Par120">Single-point continuous variables were analysed using random-intercept linear mixed-effects models that included Treatment (categorical: Placebo, CBD50, CBD300) as a fixed effect and Participant as a random effect. Sex (categorical: Male, Female), Session (i.e., trial order) (categorical: Session 1, Session 2, Session 3) or the Treatment × Sex interaction was also included as a fixed effect if it reduced the Akaike Information Criterion (AIC) value of the model. If the residuals were non-normally distributed (Shapiro–Wilk test, <em>p</em> &lt; 0.05) and/or heteroscedastic (Levene test, <em>p</em> &lt; 0.05), the dependent variable was square-root transformed and re-analysed (and if unimproved, log-transformed). If the variable included zeros, a small positive constant, equal to half the smallest non-zero value, was added to each value prior to transformation. If neither transformation was curative, a gamma generalised linear mixed-effects model, using a ‘log’ link, was substituted. If an appropriate gamma model could not be generated (e.g., it failed to converge, demonstrated overdispersion), the simplest model violating the fewest assumptions was used.</p>
<p id="Par121">Serial continuous variables were analysed using the same approach, except the models: (1) had random intercepts and slopes (for Treatment varying by Participant); (2) included Time (categorical) and the Treatment × Time interaction as fixed effects; and (3) included Sex, Session or the Treatment × Sex × Time interaction as a fixed effect if it reduced the AIC value of the model. Ordinal variables were analysed using cumulative link mixed-effects (clmm) models. These models contained the same fixed and random effects structure as specified above.</p>
<p id="Par122">Two-sided, Dunn–Šidák-corrected post hoc comparisons were used to compare estimated marginal means if a significant main or interaction effect was observed. If the effect involved Treatment, CBD50 and CBD300 were compared to placebo, only (i.e., not one another). Also, if the effect was a Time-dependent interaction, the interacting factor/s were compared at each time point (i.e., comparisons were not performed across Time to conserve power). A priori planned post hoc comparisons of FS ratings at the 40-min timepoint were also performed on each active treatment against placebo.</p>
<p id="Par123">All statistical analyses were performed in R Studio version 4.2.0 [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>] using the following packages: ‘lme4’ (lmer and glmer functions) [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>] ‘lmerTest’ [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>], ‘ordinal’ (clmm2 function) [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>], ‘RVAideMemoire’ (Anova.clmm function) [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>], ‘emmeans’ (emmeans function) [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>], ‘Car’ (Anova, qqp and LeveneTest functions) [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>], ‘MuMIn’ (AICc function) [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>] and ‘ggplot2’ (ggplot function) [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>].</p>
<p id="Par124">Statistical significance was accepted as <em>p</em> &lt; 0.05. All values are presented as Mean ± SD or Median [IQR], if normally or non-normally distributed, respectively.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Sample Size</h3>
<p id="Par125">Sahinovic et al. [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>] reported that acute CBD (300 mg; oral) increased positive affect (i.e., FS ratings) during a 60-min submaximal intensity treadmill run (~ 70% <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq28"><math id="d33e1448"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>) compared to placebo (Cohen’s d<sub><em>z</em></sub> = 0.71). Using a power (1-β) of 0.80, a two-sided Dunn–Šidák adjusted α of 0.025, (i.e., to account for two comparisons to placebo), and a comparable Cohen’s d<sub><em>z</em></sub> effect of 0.70, we determined a priori that 22 participants would be required to detect a significant effect of CBD (300 mg) on FS ratings during RUN 1. A total of 25 participants were recruited to account for possible attrition.</p></section></section><section id="Sec22"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec23"><h3 class="pmc_sec_title">Participant Recruitment and Retention</h3>
<p id="Par126">Thirty-two volunteers signed informed consent between 24th October 2022 and 29th January 2024, of whom 25 were willing and eligible to participate in the trial (Fig. <a href="#Fig2" class="usa-link">2</a>). All 25 were randomised and included in the final sample after completing all three treatment sessions. The characteristics of these participants are summarised in Table <a href="#Tab1" class="usa-link">1</a>. Briefly, the sample was mostly male (<em>n</em>=16), with an average age and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq29"><math id="d33e1484"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>2max</sub> of 30 ± 7 years and 53.1 ± 7.5 mL·kg·min<sup>−1</sup>, respectively.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/ed319b5fd7d2/40798_2025_895_Fig2_HTML.jpg" loading="lazy" id="MO2" height="400" width="784" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CONSORT diagram of the study. a. Participants were not running 40 km week<sup>−1</sup> on average for a month prior to their screening. b. Participants became unresponsive and could not be contacted</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristic</th>
<th align="left" colspan="1" rowspan="1">Frequency (n), Mean ± SD or Median [IQR]</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="2" rowspan="1"><strong>General</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Participants (n)</td>
<td align="left" colspan="1" rowspan="1">25</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">16 (64%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">9 (36%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Hormonal contraceptive use</td>
<td align="left" colspan="1" rowspan="1">2 (22%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years)</td>
<td align="left" colspan="1" rowspan="1">30 ± 7</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><strong>Anthropometrics</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Height (cm)</td>
<td align="left" colspan="1" rowspan="1">173 ± 9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Weight (kg)</td>
<td align="left" colspan="1" rowspan="1">66.5 ± 10.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Body Fat (%)</td>
<td align="left" colspan="1" rowspan="1">17.8 ± 7.3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">15.5 [9.3–17.1]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">24.5 ± 5.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lean Body Mass (%)</td>
<td align="left" colspan="1" rowspan="1">52.9 ± 10.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">58.8 ± 6.9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">42.3 ± 4.6</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><strong>Baseline aerobic capacity</strong></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq50"><math id="d33e1608"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub> (mL·min·kg<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">53.1 ± 7.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">55.5 ± 7.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">48.9 ± 6.4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Maximal Heart Rate (bpm)</td>
<td align="left" colspan="1" rowspan="1">183 ± 12</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">
<strong>Running behaviour</strong><sup>a</sup>
</td></tr>
<tr><td align="left" colspan="2" rowspan="1">Frequency (days·wk<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Minimum</td>
<td align="left" colspan="1" rowspan="1">4 [3–5]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Maximum</td>
<td align="left" colspan="1" rowspan="1">5 [4, 5]</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Distance (km·wk<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Minimum</td>
<td align="left" colspan="1" rowspan="1">40 [35–50]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Maximum</td>
<td align="left" colspan="1" rowspan="1">55 [45–60]</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><strong>Cannabis use</strong></td></tr>
<tr><td align="left" colspan="2" rowspan="1">Ever used (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">8 (32%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">17 (68%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Lifetime exposures (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤ 10 uses</td>
<td align="left" colspan="1" rowspan="1">11 (44%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt; 10 uses</td>
<td align="left" colspan="1" rowspan="1">6 (24%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Time since last use (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3–6 months</td>
<td align="left" colspan="1" rowspan="1">5 (20%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 6–12 months</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2 years</td>
<td align="left" colspan="1" rowspan="1">2 (8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 2–4 years</td>
<td align="left" colspan="1" rowspan="1">2 (8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt; 4 years</td>
<td align="left" colspan="1" rowspan="1">8 (32%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><strong>CBD use</strong></td></tr>
<tr><td align="left" colspan="2" rowspan="1">Ever used (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">19 (76%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">6 (24%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Lifetime exposures (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤ 10 uses</td>
<td align="left" colspan="1" rowspan="1">2 (8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt; 10 uses</td>
<td align="left" colspan="1" rowspan="1">4 (16%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Time since last use (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3–6 months</td>
<td align="left" colspan="1" rowspan="1">5 (20%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 6–12 months</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2 years</td>
<td align="left" colspan="1" rowspan="1">1 (4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 2–4 years</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt; 4 years</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><strong>Expectations</strong></td></tr>
<tr><td align="left" colspan="2" rowspan="1">Effect of CBD on exercise performance (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Very Negative</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Slightly Negative</td>
<td align="left" colspan="1" rowspan="1">1 (4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No Effect</td>
<td align="left" colspan="1" rowspan="1">7 (28%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Slightly Positive</td>
<td align="left" colspan="1" rowspan="1">14 (56%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Very Positive</td>
<td align="left" colspan="1" rowspan="1">3 (12%)</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1">Confidence in response (n)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Not at all</td>
<td align="left" colspan="1" rowspan="1">7 (28%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Somewhat</td>
<td align="left" colspan="1" rowspan="1">10 (40%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Moderately</td>
<td align="left" colspan="1" rowspan="1">6 (24%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Extremely</td>
<td align="left" colspan="1" rowspan="1">2 (8%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p74"><p>Values are frequency (n), mean ± SD or median [IQR], as appropriate (i.e., where data are count, normally and non-normally distributed, respectively). <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq51"><math id="d33e1859"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2max</sub>: maximal rate of oxygen consumption. a. Participants reported their minimum and maximum weekly running frequency and distances during the month prior to their recruitment</p></div></div></section></section><section id="Sec24"><h3 class="pmc_sec_title">Standardisation Procedures</h3>
<p id="Par127">All but one participant, who reported spending &lt; 8 h in bed prior to their third treatment session (7 h, CBD300), acknowledged compliance with the pre-session standardisation procedures. Sleep duration, sleep quality, hydration status (i.e., USG), pre-exercise body weight, and the laboratory conditions (i.e., temperature and humidity) did not differ significantly by Treatment (Tables <a href="#Tab2" class="usa-link">2</a> and <a href="#Tab3" class="usa-link">3</a>). On average, participants consumed 2073 ± 320 kJ, 79 ± 12 g carbohydrate, 11 ± 1 g protein and 455 ± 116 mL water for breakfast, 338 ± 120 mL water Post RUN 1, and 429 ± 117 mL Post RUN 2. Participants completed their three treatment sessions within 16 [14–22.5] days.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Descriptive statistics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Placebo (Mean ± SD) or Median [IQR]</th>
<th align="left" colspan="1" rowspan="1">50 mg CBD (Mean ± SD) or Median [IQR]</th>
<th align="left" colspan="1" rowspan="1">300 mg CBD (Mean ± SD) or Median [IQR]</th>
</tr></thead>
<tbody>
<tr><td align="left" colspan="4" rowspan="1"><em>Primary outcome</em></td></tr>
<tr><td align="left" colspan="4" rowspan="1">Feelings Scale Ratings <sub>(Scale: -5–5)</sub>
</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">20EX</td>
<td align="left" colspan="1" rowspan="1">3 [2–3]</td>
<td align="left" colspan="1" rowspan="1">3 [2–3]</td>
<td align="left" colspan="1" rowspan="1">2 [2–2]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">40EX</td>
<td align="left" colspan="1" rowspan="1">3 [1–3]</td>
<td align="left" colspan="1" rowspan="1">3 [1–3]</td>
<td align="left" colspan="1" rowspan="1">2 [1–2]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">60EX</td>
<td align="left" colspan="1" rowspan="1">3 [1–3]</td>
<td align="left" colspan="1" rowspan="1">3 [1–3]</td>
<td align="left" colspan="1" rowspan="1">2 [1–2]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"><em>Secondary outcomes</em></td></tr>
<tr><td align="left" colspan="4" rowspan="1"><em>RUN 1</em></td></tr>
<tr><td align="left" colspan="4" rowspan="1"> Heart Rate (bpm)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  20EX</td>
<td align="left" colspan="1" rowspan="1">147 [139–151]</td>
<td align="left" colspan="1" rowspan="1">144 [135–152]</td>
<td align="left" colspan="1" rowspan="1">143 [139–151]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  40EX</td>
<td align="left" colspan="1" rowspan="1">149 [145–156]</td>
<td align="left" colspan="1" rowspan="1">148 [139–153]</td>
<td align="left" colspan="1" rowspan="1">148 [142–157]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  60EX</td>
<td align="left" colspan="1" rowspan="1">152 [147–160]</td>
<td align="left" colspan="1" rowspan="1">150 [141–160]</td>
<td align="left" colspan="1" rowspan="1">149 [145–159]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Glucose (mmol L<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">5.6 ± 0.7</td>
<td align="left" colspan="1" rowspan="1">5.5 ± 0.7</td>
<td align="left" colspan="1" rowspan="1">5.4 ± 0.6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Lactate (mmol L<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">2.0 [1.2–3.2]</td>
<td align="left" colspan="1" rowspan="1">2.0 [0.98–3.0]</td>
<td align="left" colspan="1" rowspan="1">3.0 [1.6–5.4]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq52"><math id="d33e2008"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> (mL kg min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">36.1 [34.0–39.1]</td>
<td align="left" colspan="1" rowspan="1">35.1 [33.6–38.0]</td>
<td align="left" colspan="1" rowspan="1">35.7 [34.1–38.4]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">35.8 [33.2–38.9]</td>
<td align="left" colspan="1" rowspan="1">35.0 [33.2–37.6]</td>
<td align="left" colspan="1" rowspan="1">35.8 [33.8–37.8]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">35.6 [32.9–38.1]</td>
<td align="left" colspan="1" rowspan="1">34.9 [32.9–36.8]</td>
<td align="left" colspan="1" rowspan="1">35.3 [33.4–38.4]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq53"><math id="d33e2054"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> (mL min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">2482 [2053–2677]</td>
<td align="left" colspan="1" rowspan="1">2427 [1966–2651]</td>
<td align="left" colspan="1" rowspan="1">2419 [2065–2697]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">2415 [2021–2609]</td>
<td align="left" colspan="1" rowspan="1">2378 [1991–2632]</td>
<td align="left" colspan="1" rowspan="1">2422 [2076–2703]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">2419 [1997–2533]</td>
<td align="left" colspan="1" rowspan="1">2385 [1970–2605]</td>
<td align="left" colspan="1" rowspan="1">2443 [2065–2682]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq54"><math id="d33e2100"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub> (mL min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">2267 [1977–2568]</td>
<td align="left" colspan="1" rowspan="1">2335 [1887–2646]</td>
<td align="left" colspan="1" rowspan="1">2279 [1881–2636]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">2177 [1916–2504]</td>
<td align="left" colspan="1" rowspan="1">2228 [1863–2544]</td>
<td align="left" colspan="1" rowspan="1">2146 [1875–2536]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">2157 [1818–2399]</td>
<td align="left" colspan="1" rowspan="1">2199 [1846–2485]</td>
<td align="left" colspan="1" rowspan="1">2126 [1842–2509]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> RER</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">0.95 [0.94–0.97]</td>
<td align="left" colspan="1" rowspan="1">0.94 [0.93–0.99]</td>
<td align="left" colspan="1" rowspan="1">0.94 [0.92–0.97]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">0.93 [0.91–0.96]</td>
<td align="left" colspan="1" rowspan="1">0.94 [0.92–0.97]</td>
<td align="left" colspan="1" rowspan="1">0.92 [0.90–0.95]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">0.93 [0.90–0.96]</td>
<td align="left" colspan="1" rowspan="1">0.93 [0.90–0.96]</td>
<td align="left" colspan="1" rowspan="1">0.92 [0.89–0.94]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> CHO oxidation (g min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">2.7 [2.1–3.2]</td>
<td align="left" colspan="1" rowspan="1">2.7 [2.2–3.4]</td>
<td align="left" colspan="1" rowspan="1">2.6 [1.9–3.1]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">2.5 [2.0–2.8]</td>
<td align="left" colspan="1" rowspan="1">2.5 [2.1–3.1]</td>
<td align="left" colspan="1" rowspan="1">2.4 [1.8–2.9]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">2.4 [1.8–2.8]</td>
<td align="left" colspan="1" rowspan="1">2.4 [2.0–2.8]</td>
<td align="left" colspan="1" rowspan="1">2.2 [1.8–2.8]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Fat oxidation (g min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">0.19 [0.11–0.24]</td>
<td align="left" colspan="1" rowspan="1">0.18 [0.03–0.30]</td>
<td align="left" colspan="1" rowspan="1">0.23 [0.12–0.32]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">0.25 [0.12–0.31]</td>
<td align="left" colspan="1" rowspan="1">0.25 [0.10–0.39]</td>
<td align="left" colspan="1" rowspan="1">0.30 [0.16–0.39]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">0.27 [0.15–0.34]</td>
<td align="left" colspan="1" rowspan="1">0.39 [0.13–0.45]</td>
<td align="left" colspan="1" rowspan="1">0.34 [0.21–0.46]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Energy expenditure (kJ min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">52.9 [45.1–59.3]</td>
<td align="left" colspan="1" rowspan="1">52.4 [42.9–59.9]</td>
<td align="left" colspan="1" rowspan="1">50.1 [43.2–59.4]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">51.1 [43.6–57.2]</td>
<td align="left" colspan="1" rowspan="1">51.5 [42.7–58.6]</td>
<td align="left" colspan="1" rowspan="1">51.3 [43.5–58.5]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">50.4 [42.6–55.0]</td>
<td align="left" colspan="1" rowspan="1">50.7 [42.5–57.8]</td>
<td align="left" colspan="1" rowspan="1">50.5 [42.6–57.9]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Respiratory rate (breaths min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">40.5 [39.7–43.4]</td>
<td align="left" colspan="1" rowspan="1">39.4 [34.8–43.4]</td>
<td align="left" colspan="1" rowspan="1">39.6 [32.5–44–6]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">42.4 [39.8–46.1]</td>
<td align="left" colspan="1" rowspan="1">41.4 [37.9–46.8]</td>
<td align="left" colspan="1" rowspan="1">40.9 ± 7.5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">42.7 [36.9–47.4]</td>
<td align="left" colspan="1" rowspan="1">41.1 [35.8–44.2]</td>
<td align="left" colspan="1" rowspan="1">41.9 ± 9.2</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Tidal volume (mL)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">1632 [1383–1945]</td>
<td align="left" colspan="1" rowspan="1">1729 [1401–2017]</td>
<td align="left" colspan="1" rowspan="1">1642 [1409–1915]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">1504 [1359–1865]</td>
<td align="left" colspan="1" rowspan="1">1574 [1288–1801]</td>
<td align="left" colspan="1" rowspan="1">1542 [1359–1862]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">1474 [1414–1841]</td>
<td align="left" colspan="1" rowspan="1">1608 [1326–1784]</td>
<td align="left" colspan="1" rowspan="1">1534 [1307–1791]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Minute ventilation (L min<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  24EX</td>
<td align="left" colspan="1" rowspan="1">64.9 [60.5–74.0]</td>
<td align="left" colspan="1" rowspan="1">63.9 [58.3–72.7]</td>
<td align="left" colspan="1" rowspan="1">64.2 [58.8–73.0]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  37EX</td>
<td align="left" colspan="1" rowspan="1">65.4 [57.7–72.5]</td>
<td align="left" colspan="1" rowspan="1">66.0 [58.7–70.9]</td>
<td align="left" colspan="1" rowspan="1">64.6 [60.3–68.0]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  50EX</td>
<td align="left" colspan="1" rowspan="1">64.6 [57.2–70.2]</td>
<td align="left" colspan="1" rowspan="1">64.4 [56.6–69.0]</td>
<td align="left" colspan="1" rowspan="1">64.1 [57.4–69.0]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Fluid Loss (L)</td>
<td align="left" colspan="1" rowspan="1">1.1 [0.9–1.2]</td>
<td align="left" colspan="1" rowspan="1">1.1 [0.8–1.1]</td>
<td align="left" colspan="1" rowspan="1">1.1 [0.8–1.2]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> RPE (Scale: 6–20)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  20EX</td>
<td align="left" colspan="1" rowspan="1">11 [10–12]</td>
<td align="left" colspan="1" rowspan="1">11 [10–12]</td>
<td align="left" colspan="1" rowspan="1">11 [10–12]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  40EX</td>
<td align="left" colspan="1" rowspan="1">11 [11, 12]</td>
<td align="left" colspan="1" rowspan="1">11 [11, 12]</td>
<td align="left" colspan="1" rowspan="1">11 [11, 12]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  60EX</td>
<td align="left" colspan="1" rowspan="1">11 [11–13]</td>
<td align="left" colspan="1" rowspan="1">12 [11, 12]</td>
<td align="left" colspan="1" rowspan="1">12 [11–13]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> S-PACES (Scale: 8–56)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  20EX</td>
<td align="left" colspan="1" rowspan="1">25 [19–29]</td>
<td align="left" colspan="1" rowspan="1">26 [19–33]</td>
<td align="left" colspan="1" rowspan="1">27 [17–33]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  40EX</td>
<td align="left" colspan="1" rowspan="1">25 [18–30]</td>
<td align="left" colspan="1" rowspan="1">26 [20–31]</td>
<td align="left" colspan="1" rowspan="1">28 [18–33]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  60EX</td>
<td align="left" colspan="1" rowspan="1">26 [18–31]</td>
<td align="left" colspan="1" rowspan="1">27 [21–31]</td>
<td align="left" colspan="1" rowspan="1">27 [20–36]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Pain (Scale: 0–100)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  20EX</td>
<td align="left" colspan="1" rowspan="1">10 [0–20]</td>
<td align="left" colspan="1" rowspan="1">10 [0–20]</td>
<td align="left" colspan="1" rowspan="1">10 [0–20]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  40EX</td>
<td align="left" colspan="1" rowspan="1">10 [5–20]</td>
<td align="left" colspan="1" rowspan="1">10 [0–20]</td>
<td align="left" colspan="1" rowspan="1">10 [0–20]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  60EX</td>
<td align="left" colspan="1" rowspan="1">10 [0–25]</td>
<td align="left" colspan="1" rowspan="1">10 [0–15]</td>
<td align="left" colspan="1" rowspan="1">15 [5–30]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"><em>RUN 2</em></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Time to Exhaustion (min)</td>
<td align="left" colspan="1" rowspan="1">16.4 ± 4.4</td>
<td align="left" colspan="1" rowspan="1">16.9 ± 5.2</td>
<td align="left" colspan="1" rowspan="1">16.6 ± 5.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Heart Rate (bpm)</td>
<td align="left" colspan="1" rowspan="1">182 ± 9</td>
<td align="left" colspan="1" rowspan="1">183 ± 9</td>
<td align="left" colspan="1" rowspan="1">182 ± 9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glucose (mmol·L<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">6.4 ± 1.3</td>
<td align="left" colspan="1" rowspan="1">7.0 ± 1.2</td>
<td align="left" colspan="1" rowspan="1">6.3 ± 1.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lactate (mmol·L<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">7.9 [6.3–10.2]</td>
<td align="left" colspan="1" rowspan="1">10.0 [6.5–12.3]</td>
<td align="left" colspan="1" rowspan="1">9.5 [6.9–10.4]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq55"><math id="d33e2522"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub> (mL kg min<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">51.8 ± 7.5</td>
<td align="left" colspan="1" rowspan="1">52.2 ± 8.2</td>
<td align="left" colspan="1" rowspan="1">51.9 ± 7.7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq56"><math id="d33e2547"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub> (mL min<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">3081 [2814–4012]</td>
<td align="left" colspan="1" rowspan="1">3089 [2852–4084]</td>
<td align="left" colspan="1" rowspan="1">3196 [2871–4080]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq57"><math id="d33e2571"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2peak</sub> (mL min<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">3426 [3216–4402]</td>
<td align="left" colspan="1" rowspan="1">3533 [3179–4694]</td>
<td align="left" colspan="1" rowspan="1">3567 [3105–4862]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak RER</td>
<td align="left" colspan="1" rowspan="1">1.12 ± 0.05</td>
<td align="left" colspan="1" rowspan="1">1.13 ± 0.05</td>
<td align="left" colspan="1" rowspan="1">1.11 ± 0.05</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Respiratory Rate (breaths min<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">48.5 [43.8–55.6]</td>
<td align="left" colspan="1" rowspan="1">48.2 [43.3–58.6]</td>
<td align="left" colspan="1" rowspan="1">50.1 [42.9–57.8]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Tidal Volume (mL)</td>
<td align="left" colspan="1" rowspan="1">2240 [2080–2517]</td>
<td align="left" colspan="1" rowspan="1">2287 [2113–2603]</td>
<td align="left" colspan="1" rowspan="1">2238 [2039–2636]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Minute Ventilation (L min<sup>−1</sup>)</td>
<td align="left" colspan="1" rowspan="1">108.8 [94.0–137.4]</td>
<td align="left" colspan="1" rowspan="1">111.2 [97.2–139.4]</td>
<td align="left" colspan="1" rowspan="1">115.4 [91.5–134.5]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fluid Loss (L)</td>
<td align="left" colspan="1" rowspan="1">0.4 [0.2–0.5]</td>
<td align="left" colspan="1" rowspan="1">0.3 [0.2–0.5]</td>
<td align="left" colspan="1" rowspan="1">0.4 [0.3–0.6]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"><em>Muscle and GI damage markers</em></td></tr>
<tr><td align="left" colspan="4" rowspan="1"> Creatine kinase (ng mL<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Baseline</td>
<td align="left" colspan="1" rowspan="1">15.4 [10.0–25.4]</td>
<td align="left" colspan="1" rowspan="1">21.2 [9.4–34.8]</td>
<td align="left" colspan="1" rowspan="1">17.4 [12.1–29.9]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 1</td>
<td align="left" colspan="1" rowspan="1">18.9 [11.4–30.8]</td>
<td align="left" colspan="1" rowspan="1">23.3 [11.9–44.1]</td>
<td align="left" colspan="1" rowspan="1">20.9 [14.2–30.1]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">17.7 [12.8–33.4]</td>
<td align="left" colspan="1" rowspan="1">27.4 [14.1–44.2]</td>
<td align="left" colspan="1" rowspan="1">23.2 [15.6–38.3]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  1h Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">19.0 [12.1–31.5]</td>
<td align="left" colspan="1" rowspan="1">25.9 [14.5–43.7]</td>
<td align="left" colspan="1" rowspan="1">24.0 [13.6–35.9]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Myoglobin (ng mL<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Baseline</td>
<td align="left" colspan="1" rowspan="1">22.5 [18.0–26.5]</td>
<td align="left" colspan="1" rowspan="1">21.6 [17.3–27.8]</td>
<td align="left" colspan="1" rowspan="1">23.4 [19.4–31.4]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 1</td>
<td align="left" colspan="1" rowspan="1">26.4 [20.1–29.6]</td>
<td align="left" colspan="1" rowspan="1">29.5 [21.8–31.9]</td>
<td align="left" colspan="1" rowspan="1">25.1 [19.8–35.9]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">26.6 [21.9–31.3]</td>
<td align="left" colspan="1" rowspan="1">28.1[22.7–34.6]</td>
<td align="left" colspan="1" rowspan="1">25.9 [21.9–36.8]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  1h Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">28.6 [20.9–34.3]</td>
<td align="left" colspan="1" rowspan="1">31.2 [25.7–42.7]</td>
<td align="left" colspan="1" rowspan="1">29.4 [22.7–41.0]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"> Lipopolysaccharide (EU mL<sup>−1</sup>)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Baseline</td>
<td align="left" colspan="1" rowspan="1">0.31 [0.25–0.44]</td>
<td align="left" colspan="1" rowspan="1">0.39 [0.30–0.49]</td>
<td align="left" colspan="1" rowspan="1">0.34 [0.22–0.45]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 1</td>
<td align="left" colspan="1" rowspan="1">0.50 [0.27–0.78]</td>
<td align="left" colspan="1" rowspan="1">0.53 [0.37–1.18]</td>
<td align="left" colspan="1" rowspan="1">0.42 [0.32–0.82]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">0.63 [0.50–0.90]</td>
<td align="left" colspan="1" rowspan="1">0.63 [0.45–1.18]</td>
<td align="left" colspan="1" rowspan="1">0.62 [0.38–1.07]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">  1h Post RUN 2</td>
<td align="left" colspan="1" rowspan="1">0.48 [ 0.33–0.67]</td>
<td align="left" colspan="1" rowspan="1">0.56 [0.43–0.78]</td>
<td align="left" colspan="1" rowspan="1">0.35 [0.3–1.09]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"><em>Next-day ratings</em></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Muscle soreness <sub>(Scale: 1–10)</sub>
</td>
<td align="left" colspan="1" rowspan="1">2 [2, 3]</td>
<td align="left" colspan="1" rowspan="1">2 [1–3]</td>
<td align="left" colspan="1" rowspan="1">2 [2, 3]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep quality <sub>(Scale: -5–+5)</sub>
</td>
<td align="left" colspan="1" rowspan="1">3 [2–4]</td>
<td align="left" colspan="1" rowspan="1">4 [2–5]</td>
<td align="left" colspan="1" rowspan="1">3 [2–4]</td>
</tr>
<tr><td align="left" colspan="4" rowspan="1"><em>Standardisation variables</em></td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep duration (h)</td>
<td align="left" colspan="1" rowspan="1">7.7 [7.0–8.0]</td>
<td align="left" colspan="1" rowspan="1">7.5 [7.0–8.0]</td>
<td align="left" colspan="1" rowspan="1">7.5 [6.5–8.0]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep quality <sup>a</sup>
</td>
<td align="left" colspan="1" rowspan="1">4 [4–4]</td>
<td align="left" colspan="1" rowspan="1">4 [4–4]</td>
<td align="left" colspan="1" rowspan="1">4 [4–5]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Urine specific gravity</td>
<td align="left" colspan="1" rowspan="1">1.017 ± 0.006</td>
<td align="left" colspan="1" rowspan="1">1.018 ± 0.005</td>
<td align="left" colspan="1" rowspan="1">1.017 ± 0.006</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pre-exercise body weight (kg)</td>
<td align="left" colspan="1" rowspan="1">66.4 ± 9.8</td>
<td align="left" colspan="1" rowspan="1">67.0 ± 10.1</td>
<td align="left" colspan="1" rowspan="1">67.0 ± 10.0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Temperature RUN 1 (°C)</td>
<td align="left" colspan="1" rowspan="1">22.1 [21.8–22.7]</td>
<td align="left" colspan="1" rowspan="1">22.2 [21.9–22.8]</td>
<td align="left" colspan="1" rowspan="1">22.2 [21.8–22.5]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Humidity RUN 1 (%)</td>
<td align="left" colspan="1" rowspan="1">56.0 [48.0–65.0]</td>
<td align="left" colspan="1" rowspan="1">55.0 [41.0–66.0]</td>
<td align="left" colspan="1" rowspan="1">57.0 [47.3–66.3]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Temperature RUN 2 (°C)</td>
<td align="left" colspan="1" rowspan="1">22.5 [22.1–23.1]</td>
<td align="left" colspan="1" rowspan="1">22.8 [22.2–23.5]</td>
<td align="left" colspan="1" rowspan="1">22.5 [22.2–22.8]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Humidity RUN 2 (%)</td>
<td align="left" colspan="1" rowspan="1">55.0 [43.0–62.0]</td>
<td align="left" colspan="1" rowspan="1">54.0 [40.0–65.0]</td>
<td align="left" colspan="1" rowspan="1">55.0 [44.0–65.0]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p77"><p>Values are mean ± SD or median [IQR], as appropriate (i.e., where the data are normally and non-normally distributed, respectively). SD: Standard Deviation; IQR: Interquartile Range. bpm: beats per minute; CHO: carbohydrate; S-PACES: Short-form Physical Activity Enjoyment Scale; RER: Respiratory Exchange Ratio; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq58"><math id="d33e2886"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>: Rate of carbon dioxide production; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq59"><math id="d33e2899"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>: Rate of oxygen consumption; EX: minutes of exercise a: 1 = ‘Very bad’, 2 = ‘Fairly bad’, 3 = ‘Neither bad nor good’, 3 = ‘Fairly good’, 4 = ‘Very good. b: Reported estimate of time spent asleep (i.e., not time spent in bed)</p></div></div></section><section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>The probability (p) values for the fixed effects included in each statistical analysis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" rowspan="2" colspan="1">Model</th>
<th align="left" colspan="8" rowspan="1">Fixed Effects (Probability Value)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Treatment</th>
<th align="left" colspan="1" rowspan="1">Time</th>
<th align="left" colspan="1" rowspan="1">Treatment × Time</th>
<th align="left" colspan="1" rowspan="1">Sex</th>
<th align="left" colspan="1" rowspan="1">Session</th>
<th align="left" colspan="1" rowspan="1">Treatment × Sex</th>
<th align="left" colspan="1" rowspan="1">Time × Sex</th>
<th align="left" colspan="1" rowspan="1">Treatment × Time × Sex</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Primary Outcome</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Feelings Scale Ratings</td>
<td align="left" colspan="1" rowspan="1">Ordinal</td>
<td align="left" colspan="1" rowspan="1">0.158</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.514</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Secondary Outcomes</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>RUN 1</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Heart Rate</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.241</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.784</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glucose</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.236</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lactate</td>
<td align="left" colspan="1" rowspan="1">Log</td>
<td align="left" colspan="1" rowspan="1"><strong>0.007</strong></td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq60"><math id="d33e3090"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.766</td>
<td align="left" colspan="1" rowspan="1">0.113</td>
<td align="left" colspan="1" rowspan="1">0.514</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq61"><math id="d33e3124"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.935</td>
<td align="left" colspan="1" rowspan="1">0.325</td>
<td align="left" colspan="1" rowspan="1">0.190</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq62"><math id="d33e3159"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>
</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.508</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.625</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RER</td>
<td align="left" colspan="1" rowspan="1">Standard*</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.907</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CHO Oxidation</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.400</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.712</td>
<td align="left" colspan="1" rowspan="1"><strong>0.016</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fat Oxidation</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.305</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.653</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Energy Expenditure</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.896</td>
<td align="left" colspan="1" rowspan="1"><strong>0.004</strong></td>
<td align="left" colspan="1" rowspan="1">0.386</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Respiratory Rate</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.841</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.278</td>
<td align="left" colspan="1" rowspan="1">0.162</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tidal Volume</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.990</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.515</td>
<td align="left" colspan="1" rowspan="1"><strong>0.008</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Minute Ventilation</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.751</td>
<td align="left" colspan="1" rowspan="1">0.186</td>
<td align="left" colspan="1" rowspan="1">0.183</td>
<td align="left" colspan="1" rowspan="1"><strong>0.045</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fluid Loss</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.317</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong>0.020</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPE</td>
<td align="left" colspan="1" rowspan="1">Ordinal</td>
<td align="left" colspan="1" rowspan="1">0.470</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.976</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">S–PACES</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.215</td>
<td align="left" colspan="1" rowspan="1">0.564</td>
<td align="left" colspan="1" rowspan="1">0.935</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pain</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.737</td>
<td align="left" colspan="1" rowspan="1"><strong>0.014</strong></td>
<td align="left" colspan="1" rowspan="1">0.394</td>
<td align="left" colspan="1" rowspan="1"><strong>0.028</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>RUN 2</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Time to Exhaustion</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.244</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">0.076</td>
<td align="left" colspan="1" rowspan="1"><strong>0.012</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HR<sub>peak</sub>
</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.343</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">0.055</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">0.304</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Glucose</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1"><strong>0.003</strong></td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">0.069</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lactate</td>
<td align="left" colspan="1" rowspan="1">Log</td>
<td align="left" colspan="1" rowspan="1">0.305</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq63"><math id="d33e3566"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>
</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.991</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong>0.046</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">0.053</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq64"><math id="d33e3602"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>
</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.396</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">0.054</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq65"><math id="d33e3637"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2peak</sub>
</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.214</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RER<sub>peak</sub>
</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.129</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Respiratory Rate</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.817</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">0.914</td>
<td align="left" colspan="1" rowspan="1"><strong>0.037</strong></td>
<td align="left" colspan="1" rowspan="1">0.480</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Tidal Volume</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.685</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong>0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Peak Minute Ventilation</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.612</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>0.036</strong></td>
<td align="left" colspan="1" rowspan="1">0.297</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fluid Loss</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.846</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong>0.048</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Cannabinoids</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CBD</td>
<td align="left" colspan="1" rowspan="1">Gamma*</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6-OH-CBD</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.228</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7-OH-CBD</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7-COOH-CBD</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.228</td>
<td align="left" colspan="1" rowspan="1">0.151</td>
<td align="left" colspan="1" rowspan="1"><strong>–</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Muscle and GI Damage Markers</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Creatine Kinase</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.273</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.670</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Myoglobin</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.634</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.560</td>
<td align="left" colspan="1" rowspan="1">0.376</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lipopolysaccharide</td>
<td align="left" colspan="1" rowspan="1">Gamma *</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>0.016</strong></td>
<td align="left" colspan="1" rowspan="1">0.179</td>
<td align="left" colspan="1" rowspan="1">0.108</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1"><strong>0.005</strong></td>
<td align="left" colspan="1" rowspan="1">0.096</td>
<td align="left" colspan="1" rowspan="1"><strong>0.012</strong></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Next-day Ratings</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Muscle Soreness</td>
<td align="left" colspan="1" rowspan="1">Log</td>
<td align="left" colspan="1" rowspan="1">0.070</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep Quality</td>
<td align="left" colspan="1" rowspan="1">Ordinal</td>
<td align="left" colspan="1" rowspan="1">0.386</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">0.078</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Standardisation variables</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep Duration</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.181</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sleep Quality</td>
<td align="left" colspan="1" rowspan="1">Ordinal</td>
<td align="left" colspan="1" rowspan="1">0.125</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Urine Specific Gravity</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.751</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Body mass</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.808</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1"><strong>0.002</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Temperature—RUN 1</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.284</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Humidity—RUN 1</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.693</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">0.084</td>
<td align="left" colspan="1" rowspan="1">0.792</td>
<td align="left" colspan="1" rowspan="1">0.314</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Temperature—RUN 2</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.068</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Humidity—RUN 2</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.752</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">0.109</td>
<td align="left" colspan="1" rowspan="1">0.726</td>
<td align="left" colspan="1" rowspan="1">0.366</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Questionnaires</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PACES</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total Score</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.627</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.808</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>State Trait Anxiety Inventory</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total Score</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.510</td>
<td align="left" colspan="1" rowspan="1">0.440</td>
<td align="left" colspan="1" rowspan="1">0.963</td>
<td align="left" colspan="1" rowspan="1">0.986</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Profile of Mood States</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total Mood Disturbance</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.744</td>
<td align="left" colspan="1" rowspan="1">0.456</td>
<td align="left" colspan="1" rowspan="1">0.924</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tension</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.978</td>
<td align="left" colspan="1" rowspan="1"><strong>0.003</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>0.008</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1"><strong>0.014</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Depression</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.725</td>
<td align="left" colspan="1" rowspan="1">0.426</td>
<td align="left" colspan="1" rowspan="1"><strong>0.008</strong></td>
<td align="left" colspan="1" rowspan="1">0.145</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fatigue</td>
<td align="left" colspan="1" rowspan="1">Sqrt</td>
<td align="left" colspan="1" rowspan="1">0.253</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.884</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Confusion</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.851</td>
<td align="left" colspan="1" rowspan="1">0.554</td>
<td align="left" colspan="1" rowspan="1">0.878</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anger</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.644</td>
<td align="left" colspan="1" rowspan="1"><strong>0.003</strong></td>
<td align="left" colspan="1" rowspan="1"><strong>0.005</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vigour</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.272</td>
<td align="left" colspan="1" rowspan="1"><strong>0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.639</td>
<td align="left" colspan="1" rowspan="1">0.203</td>
<td align="left" colspan="1" rowspan="1"><strong>0.030</strong></td>
<td align="left" colspan="1" rowspan="1">0.142</td>
<td align="left" colspan="1" rowspan="1">0.404</td>
<td align="left" colspan="1" rowspan="1">0.166</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Esteem</td>
<td align="left" colspan="1" rowspan="1">Standard</td>
<td align="left" colspan="1" rowspan="1">0.275</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.604</td>
<td align="left" colspan="1" rowspan="1">0.538</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1"><strong>0.014</strong></td>
<td align="left" colspan="1" rowspan="1">0.411</td>
<td align="left" colspan="1" rowspan="1">0.222</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Gastrointestinal comfort</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Abdominal  Discomfort</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.845</td>
<td align="left" colspan="1" rowspan="1">0.563</td>
<td align="left" colspan="1" rowspan="1">0.656</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Abdominal Pain</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.057</td>
<td align="left" colspan="1" rowspan="1">0.071</td>
<td align="left" colspan="1" rowspan="1"><strong>0.028</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Belching</td>
<td align="left" colspan="1" rowspan="1">Gamma*</td>
<td align="left" colspan="1" rowspan="1"><strong>0.046</strong></td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.451</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Bloating</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.276</td>
<td align="left" colspan="1" rowspan="1">0.054</td>
<td align="left" colspan="1" rowspan="1">0.413</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Flatulence</td>
<td align="left" colspan="1" rowspan="1">Gamma *</td>
<td align="left" colspan="1" rowspan="1">0.206</td>
<td align="left" colspan="1" rowspan="1">0.266</td>
<td align="left" colspan="1" rowspan="1">0.591</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nausea</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.102</td>
<td align="left" colspan="1" rowspan="1"><strong>0.020</strong></td>
<td align="left" colspan="1" rowspan="1">0.567</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Regurgitation</td>
<td align="left" colspan="1" rowspan="1">Gamma*</td>
<td align="left" colspan="1" rowspan="1"><strong>0.016</strong></td>
<td align="left" colspan="1" rowspan="1">0.242</td>
<td align="left" colspan="1" rowspan="1">0.885</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><strong>Resting measures</strong></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Resting Heart Rate</td>
<td align="left" colspan="1" rowspan="1">Log</td>
<td align="left" colspan="1" rowspan="1">0.255</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.515</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Systolic Blood Pressure</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.652</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.136</td>
<td align="left" colspan="1" rowspan="1"><strong>0.037</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diastolic Blood Pressure</td>
<td align="left" colspan="1" rowspan="1">Gamma</td>
<td align="left" colspan="1" rowspan="1">0.375</td>
<td align="left" colspan="1" rowspan="1"><strong> &lt; 0.001</strong></td>
<td align="left" colspan="1" rowspan="1">0.146</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1"><strong>0.031</strong></td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p79"><p>Not Required (i.e., did not reduce the AIC value of the model); Log: The dependent variable was log transformed; n/a: Not Applicable; Sqrt: The dependent variable was square-root transformed. EX: minutes of exercise; HR: Heart Rate; RER: Respiratory Exchange Ratio; RPE: Ratings of Perceived Exertion; S-PACES: Short form Physical Activity Enjoyment Scale; VAS: Visual Analogue Scale <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq66"><math id="d33e4799"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>: rate of oxygen consumption; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq67"><math id="d33e4812"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>: rate of carbon dioxide production *The random effects structure was reduced (random intercept, only) due to convergence issues</p></div></div></section></section><section id="Sec25"><h3 class="pmc_sec_title">Plasma Cannabinoid Concentrations</h3>
<p id="Par128">Plasma CBD, 7-COOH-CBD, 7-OH-CBD and 6-OH-CBD concentrations are displayed in Figs. <a href="#Fig3" class="usa-link">3</a> and <a href="#Fig4" class="usa-link">4</a>. <em>C</em><sub>max</sub> on CBD50 and CBD300 was 11.7 [6.7–15.3] and 143.3 [94.1–203.6] ng∙mL<sup>−1</sup>, respectively. T<sub>max</sub> was estimated to be 205 [205–205] and 205 [155–205] minutes, respectively. THC, 11-OH-THC, 11-COOH-THC and CBDV were not detected in any samples.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/df3bfe35d04f/40798_2025_895_Fig3_HTML.jpg" loading="lazy" id="MO3" height="1367" width="582" alt="Fig. 3"></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plasma concentration over time profiles for CBD and CBD metabolites during CBD300 <strong>(a)</strong> and CBD50 <strong>(b)</strong> treatment. Venous blood was collected -10-(Baseline), 75- (Pre RUN 1), 155–(Post RUN 1), 205- (Post RUN 2) and 265- (1h Post RUN 2) minutes post-drug administration. Values are mean ± SD</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/c7579bd16f9a/40798_2025_895_Fig4_HTML.jpg" loading="lazy" id="MO4" height="865" width="598" alt="Fig. 4"></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Individual plasma CBD and CBD metabolite concentrations over time during CBD300 (dark green circles) and CBD50 (light green squares) treatment. <strong>a</strong> CBD concentrations with CBD300 treatment; <strong>b</strong> CBD concentrations with CBD50 treatment; <strong>c</strong> 6-OH-CBD concentrations with CBD300 treatment; <strong>d</strong> 6-OH-CBD concentrations with CBD50 treatment; <strong>e</strong> 7-OH-CBD concentrations with CBD300 treatment; <strong>f</strong> 7-OH-CBD concentrations with CBD50 treatment; <strong>g</strong> 7-COOH-CBD concentrations with CBD300 treatment; <strong>h</strong> 7-COOH-CBD concentrations with CBD50 treatment. Lines represent individual participant concentrations</p></figcaption></figure><p id="Par129">When subjected to further analysis, CBD, 6-OH-CBD, 7-OH-CBD and 7-COOH-CBD all demonstrated significant main effects of Treatment, Time and Treatment × Time interactions (Table <a href="#Tab3" class="usa-link">3</a>). Where Sex or Session were included in the final model, no significant Sex, Session or Treatment × Sex interaction effects were observed. Post hoc analyses of the Treatment × Time interactions revealed significant differences between all treatments at each timepoint (Supplementary File 1).</p>
<p id="Par130">Although all treatment sessions were separated by a washout period ≥ 7 days (7 [7–10] days), there were twenty occasions where participants were found to have low (but detectable) concentrations of the CBD metabolite, 7-COOH-CBD (≤ 9.9 ng·mL<sup>−1</sup>), which has largely been demonstrated to be inactive [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], in plasma at Baseline on their second or third treatment session. Ten of these occasions were during a Placebo session (all ≤ 7.1 ng·mL<sup>−1</sup>). One participant also had very low concentrations of 6-OH-CBD at Baseline during their CBD50 session, while another had very low concentrations of CBD at Post RUN 1 during their Placebo session. Neither of these concentrations exceeded the lower limit of quantitation (LLOQ; 0.5 ng·mL<sup>−1</sup>).</p></section><section id="Sec26"><h3 class="pmc_sec_title">Primary Outcome</h3>
<p id="Par131">FS ratings did not demonstrate a significant main effect of Treatment or a Treatment × Time interaction (Table <a href="#Tab3" class="usa-link">3</a>; Fig. <a href="#Fig5" class="usa-link">5</a>). Likewise, a priori planned post hoc comparisons of FS ratings between Placebo and CBD50 (<em>p</em> = 0.177) and Placebo and CBD300 (<em>p</em> = 0.995) at the 40-min time point of RUN 1 found no differences between the treatments. A significant main effect of Time was observed (Table <a href="#Tab3" class="usa-link">3</a>), with post hoc analyses revealing higher FS ratings at 20- compared to both 40- (<em>p</em> = 0.005) and 60- (<em>p</em> &lt; 0.001) minutes of RUN 1.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/83a6dbf74913/40798_2025_895_Fig5_HTML.jpg" loading="lazy" id="MO5" height="465" width="706" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Subjective outcomes collected during RUN 1. <strong>a</strong> Affective valence; <strong>b</strong> perceived exertion; <strong>c</strong> pain; <strong>d</strong> enjoyment. <strong>EX</strong>: minutes of exercise; <strong>RPE</strong>: Ratings of Perceived Exertion<strong>; S-PACES</strong>: Short form Physical Activity Enjoyment Scale; <strong>VAS</strong>: Visual Analogue Scale. ‘ + ’ represents the mean value. <em>a:</em> differs from 20EX (<em>p</em>’s &lt; 0.05)</p></figcaption></figure></section><section id="Sec27"><h3 class="pmc_sec_title">Secondary Outcomes</h3>
<p id="Par132">Results of secondary analyses are presented herein. All significant main and interaction effects, as well as all post hoc comparisons by Treatment and Session (including their interactions), are described below. Post hoc comparisons by Time are described below for CK, Myo and LPS, only. All other post hoc comparisons by Time and Sex are presented in Supplementary File 1.</p>
<section id="Sec28"><h4 class="pmc_sec_title">Subjective Measures (RUN 1)</h4>
<p id="Par133">No significant main effects of Treatment or Treatment × Time interactions were observed for RPE, S-PACES or Pain (Table <a href="#Tab3" class="usa-link">3</a>, Fig. <a href="#Fig5" class="usa-link">5</a>). Both RPE and Pain demonstrated main effects of Time; Pain also demonstrated a main effect of Sex (Table <a href="#Tab3" class="usa-link">3</a>, Supplementary File 1).</p></section><section id="Sec29"><h4 class="pmc_sec_title">Physiological Outcomes (RUN 1)</h4>
<p id="Par134">No significant main effects of Treatment or Treatment × Time interactions were observed for HR, blood glucose, relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq30"><math id="d33e4993"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>, absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq31"><math id="d33e5006"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq32"><math id="d33e5019"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>, CHOox, FATox, EE, RR, V<sub>T</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq33"><math id="d33e5035"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>E</sub> or fluid loss (Table <a href="#Tab3" class="usa-link">3</a>; Figs. <a href="#Fig6" class="usa-link">6</a> and <a href="#Fig7" class="usa-link">7</a>). RER and blood lactate demonstrated main effects of Treatment (Table <a href="#Tab3" class="usa-link">3</a>; Figs. <a href="#Fig7" class="usa-link">7</a> and <a href="#Fig8" class="usa-link">8</a>). Post hoc analyses revealed a lower RER with CBD300 (<em>p</em> = 0.030) but not CBD50 (<em>p</em> = 0.195) compared to Placebo. No significant differences in blood lactate were observed with CBD300 (<em>p</em> = 0.053) or CBD50 (<em>p</em> = 0.599) compared to Placebo. HR, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq34"><math id="d33e5079"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>, RER, CHOox, FATox, EE, RR V<sub>T</sub> demonstrated main effects of Time; absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq35"><math id="d33e5094"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq36"><math id="d33e5108"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>, CHOox, EE, V<sub>T</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq37"><math id="d33e5123"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>E</sub> and fluid loss also demonstrated main effects of Sex (Table <a href="#Tab3" class="usa-link">3</a>, Supplementary File 1).</p>
<figure class="fig xbox font-sm" id="Fig6"><h5 class="obj_head">Fig. 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/87fe01f0d41c/40798_2025_895_Fig6_HTML.jpg" loading="lazy" id="MO6" height="457" width="708" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cardiorespiratory measures collected during RUN 1. <strong>a.</strong> Heart Rate; <strong>b.</strong> Respiratory Rate; <strong>c.</strong> Tidal Volume; <strong>d.</strong> Minute Ventilation. bpm: beats per minute; EX: minutes of exercise; RER: Respiratory Exchange Ratio; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq69"><math id="d33e5157"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>: rate of oxygen consumption; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq70"><math id="d33e5171"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>: rate of carbon dioxide production. ‘ + ’ represents the mean value <em>a:</em> differs from 20EX, <em>b:</em> differs from 40EX: <em>c:</em> differs from 24EX, <em>d:</em> differs from 37EX (<em>p</em>’s &lt; 0.05)</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig7"><h5 class="obj_head">Fig. 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/1fbb75bcfa63/40798_2025_895_Fig7_HTML.jpg" loading="lazy" id="MO7" height="958" width="708" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Metabolic measures collected during RUN 1. <strong>a.</strong> Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq71"><math id="d33e5211"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>; <strong>b.</strong> Absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq72"><math id="d33e5227"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>; <strong>c.</strong>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq73"><math id="d33e5244"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>; <strong>d.</strong> RER; <strong>e.</strong> Carbohydrate Oxidation; <strong>f.</strong> Fat Oxidation; <strong>g.</strong> Energy Expenditure <strong>CHO</strong>: carbohydrate; <strong>EX</strong>: minutes of exercise; <strong>RER</strong>: Respiratory Exchange Ratio; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq74"><math id="d33e5279"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><strong>O</strong><sub><strong>2</strong></sub>: rate of oxygen consumption; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq75"><math id="d33e5296"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><strong>CO</strong><sub><strong>2</strong></sub>: rate of carbon dioxide production. ‘ + ’ represents the mean value. <em>c:</em> differs from 24EX, <em>d:</em> differs from 37EX (<em>p</em>’s &lt; 0.05)</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig8"><h5 class="obj_head">Fig. 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/d34ee8ad27bf/40798_2025_895_Fig8_HTML.jpg" loading="lazy" id="MO8" height="309" width="779" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Capillary blood lactate <strong>(a)</strong> and glucose <strong>(b)</strong> concentrations collected upon cessation of RUN 1. Individual shapes represent individual participant values; bars represent mean values. *: differs from Placebo (<em>p</em> &lt; 0.05)</p></figcaption></figure></section><section id="Sec30"><h4 class="pmc_sec_title">Physiological Outcomes (RUN 2)</h4>
<p id="Par135">No significant main effects of Treatment were observed for TTE, HR<sub>peak</sub>, relative and absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq38"><math id="d33e5347"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak,</sub>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq39"><math id="d33e5360"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2peak,</sub> RER<sub>peak</sub>, RR<sub>peak</sub>, V<sub>Tpeak</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq40"><math id="d33e5380"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>Epeak</sub> or blood lactate concentrations during RUN 2 (Table <a href="#Tab3" class="usa-link">3</a>). Blood glucose demonstrated a main effect of Treatment (Table <a href="#Tab3" class="usa-link">3</a>, Fig. <a href="#Fig9" class="usa-link">9</a>) with post hoc analyses revealing higher concentrations for CBD50 (<em>p</em> = 0.003) but not CBD300 (<em>p</em> = 0.888) compared to Placebo. Relative <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq41"><math id="d33e5408"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>, absolute <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq42"><math id="d33e5422"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak,</sub> V<sub>Tpeak</sub>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq43"><math id="d33e5437"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span><sub>Epeak</sub>, blood lactate, and fluid loss all demonstrated a main effect of Sex (Table <a href="#Tab3" class="usa-link">3</a>, see Supplementary File 1). TTE, RR<sub>peak</sub> and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq44"><math id="d33e5455"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>E<sub>peak</sub> also demonstrated a main effect of Session (Table <a href="#Tab3" class="usa-link">3</a>). Post hoc analyses revealed lower TTE (<em>p</em> = 0.012) and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq45"><math id="d33e5474"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>E<sub>peak</sub> (<em>p</em> = 0.042) on Session 1 compared to Session 2. No other significant differences (including differences in RR<sub>peak</sub>) were observed.</p>
<figure class="fig xbox font-sm" id="Fig9"><h5 class="obj_head">Fig. 9.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig9_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/37f97687433c/40798_2025_895_Fig9_HTML.jpg" loading="lazy" id="MO9" height="1006" width="795" alt="Fig. 9"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Performance measures collected during RUN 2. <strong>a.</strong> Time to Exhaustion; <strong>b.</strong> Peak Heart Rate; <strong>c.</strong>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq76"><math id="d33e5508"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>; <strong>d.</strong> RER<sub>peak</sub>; <strong>e.</strong> Lactate concentrations; <strong>f.</strong> Glucose concentrations. RER: Respiratory Exchange Ratio; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq77"><math id="d33e5533"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>: rate of oxygen consumption; <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq78"><math id="d33e5547"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>CO<sub>2</sub>: rate of carbon dioxide production. Individual shapes represent individual participant values; bars represent mean values. *: differs from Placebo (<em>p</em> &lt; 0.05)</p></figcaption></figure></section><section id="Sec31"><h4 class="pmc_sec_title">Muscle Damage and GI Barrier Function Markers</h4>
<p id="Par136">LPS demonstrated a main effect of Treatment, Time, a Treatment × Sex interaction and a Treatment × Time × Sex interaction (Table <a href="#Tab3" class="usa-link">3</a>, Figs. <a href="#Fig10" class="usa-link">10</a> and <a href="#Fig11" class="usa-link">11</a>). Post hoc analyses of the main effect of Treatment revealed higher concentrations of LPS with CBD50 (<em>p</em> = 0.013), but not CBD300 (<em>p</em> = 1.000), compared to Placebo. Post hoc analyses of the Treatment × Time × Sex interaction effect revealed higher LPS concentrations in females at Post RUN 2 with CBD50 compared to Placebo (<em>p</em> = 0.032). Post hoc analyses of the main effect of Time revealed higher LPS concentrations Post RUN 1, Post RUN 2 and 1h Post RUN 2 compared to Baseline (all <em>p</em>’s &lt; 0.001). No other significant differences were observed.</p>
<figure class="fig xbox font-sm" id="Fig10"><h5 class="obj_head">Fig. 10.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/426bfa83cf05/40798_2025_895_Fig10_HTML.jpg" loading="lazy" id="MO10" height="373" width="596" alt="Fig. 10"></p>
<div class="p text-right font-secondary"><a href="figure/Fig10/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plasma lipopolysaccharide concentrations in <strong>a.</strong> Male participants (<em>n</em> = 16) and <strong>b.</strong> Female participants (<em>n</em> = 9). <strong>BSL:</strong> Baseline; <strong>POST:</strong> 1h Post RUN 2. Values are Mean ± SD.*: CBD50 differs from Placebo (<em>p</em> &lt; 0.05);<em> a</em>: differs from Baseline (<em>p</em>’s &lt; 0.05)</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig11"><h5 class="obj_head">Fig. 11.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig11_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/a440ab5fb17f/40798_2025_895_Fig11_HTML.jpg" loading="lazy" id="MO11" height="173" width="708" alt="Fig. 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig11/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Exercise enjoyment as measured by the 18-item Physical Activity Enjoyment Scale (PACES) before exercise (PRE) and after RUN 1 and RUN 2. ‘ + ’ represents the mean value</p></figcaption></figure><p id="Par137">No significant main effects of Treatment or Treatment × Time interactions were observed for CK or Myo (Table <a href="#Tab3" class="usa-link">3</a>, Fig. <a href="#Fig10" class="usa-link">10</a>). However, both biomarkers demonstrated significant main effects of Time. Post hoc analyses of CK revealed higher concentrations Post RUN 1, Post RUN 2 and 1h Post RUN 2 compared to Baseline (all <em>p</em>’s &lt; 0.001), and higher concentrations Post RUN 2 (<em>p</em> = 0.001) and 1h Post RUN 2 (<em>p</em> = 0.017) compared to Post RUN 1. Post hoc analysis of Myo revealed higher concentrations Post RUN 1, Post RUN 2 and 1h Post RUN 2 compared to Baseline, and higher concentrations 1h Post RUN 2 compared to Post RUN 1 (all <em>p</em>’s &lt; 0.001).</p></section><section id="Sec32"><h4 class="pmc_sec_title">Resting Heart Rate and Blood Pressure</h4>
<p id="Par138">There was no significant main effect of Treatment or Treatment × Time interaction for resting HR, systolic BP or diastolic BP (Table <a href="#Tab3" class="usa-link">3</a>, Supplementary File 1). All three outcomes demonstrated main effects of Time; systolic BP also demonstrated a main effect of Sex (Table <a href="#Tab3" class="usa-link">3</a>, see Supplementary File 1). Diastolic BP demonstrated a main effect of Session (Table <a href="#Tab3" class="usa-link">3</a>) with post hoc analyses revealing lower values on Session 3 compared to Session 1 (<em>p</em> = 0.025).</p></section><section id="Sec33"><h4 class="pmc_sec_title">Anxiety</h4>
<p id="Par139">There were no significant Treatment, Time or Treatment × Time interactions for STAI-S ratings (Table <a href="#Tab3" class="usa-link">3</a>, see Supplementary File 1).</p></section><section id="Sec34"><h4 class="pmc_sec_title">Mood</h4>
<p id="Par140">Total Mood Disturbance (TMD) and all subscales of the POMS demonstrated no main effect of Treatment. Tension (<em>p</em> = 0.008), Anger (<em>p</em> = 0.005) and Depression (<em>p</em> = 0.008) all demonstrated Treatment × Time interactions. However, none of the post hoc analyses identified differences between the treatments. Esteem demonstrated a significant Treatment × Sex interaction effect (<em>p</em> = 0.014), however post hoc analyses did not identify any significant differences. Tension, Fatigue, Anger, Vigour and Esteem all demonstrated main effects of Time (see Supplementary File 1). Tension (<em>p</em> = 0.014), Confusion (<em>p</em> &lt; 0.001) and Vigour (<em>p</em> = 0.030) also demonstrated main effects of Session. Post hoc analyses revealed: higher ratings of Tension (<em>p</em> = 0.012) and Confusion (<em>p</em> &lt; 0.001) on Session 1 compared to Session 2; and higher ratings of Confusion on Session 1 compared to Session 3 (<em>p</em> = 0.017). No other significant differences (including differences in Vigour) were observed.</p></section><section id="Sec35"><h4 class="pmc_sec_title">Exercise Enjoyment (PACES)</h4>
<p id="Par141">There was no main effect of Treatment or Treatment × Time interaction for exercise enjoyment, as measured by the long-form PACES (Table <a href="#Tab3" class="usa-link">3</a>, Fig. <a href="#Fig12" class="usa-link">12</a>); however, a significant main effect of Time was observed (Supplementary File 1).</p>
<figure class="fig xbox font-sm" id="Fig12"><h5 class="obj_head">Fig. 12.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370602_40798_2025_895_Fig12_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55d/12370602/f104208becfd/40798_2025_895_Fig12_HTML.jpg" loading="lazy" id="MO12" height="251" width="777" alt="Fig. 12"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig12/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Muscle and gastrointestinal damage biomarkers. <strong>a.</strong> Creatine Kinase; <strong>b.</strong> Myoglobin; <strong>c.</strong> Lipopolysaccharide. BSL: Baseline; POST: 1h Post RUN 2. Values are Mean ± SD. <em>a</em>: differs from Baseline, <em>b</em>: differs from Post RUN 1, <em>c</em>: differs from Post RUN 2 (<em>p</em>’s &lt; 0.05)</p></figcaption></figure></section><section id="Sec36"><h4 class="pmc_sec_title">Gastrointestinal Comfort</h4>
<p id="Par142">Abdominal Pain demonstrated a significant Treatment × Time interaction (<em>p</em> = 0.028), however post hoc analyses revealed no significant differences between the treatments. There were no other significant Treatment × Time interactions for measures of gastrointestinal comfort (Table <a href="#Tab3" class="usa-link">3</a>, see Supplementary File 1). Belching and Regurgitation demonstrated main effects of Treatment with post hoc analyses revealing higher ratings of Belching for CBD300 (<em>p</em> = 0.043) but not CBD50 (<em>p</em> = 0.104) compared to Placebo, and higher ratings of Regurgitation with CBD50 (<em>p</em> = 0.018) but not CBD300 (<em>p</em> = 0.947) compared to Placebo. Belching and Nausea both demonstrated main effects of Time (Table <a href="#Tab3" class="usa-link">3</a>, Supplementary File 1).</p></section><section id="Sec37"><h4 class="pmc_sec_title">Next Day Muscle Soreness and Sleep Quality</h4>
<p id="Par143">Sleep quality and next day muscle soreness did not differ significantly by Treatment (Table <a href="#Tab3" class="usa-link">3</a>).</p></section></section><section id="Sec38"><h3 class="pmc_sec_title">Blinding</h3>
<p id="Par144">Eight (32%), 10 (40%) and four (16%) of the 25 participants correctly identified the treatment session where they received Placebo, CBD50 and CBD300, respectively. None were more than ‘moderately confident’ in their guess. All other responses were either incorrect (<em>n</em> = 37/75; 49%) or ‘unsure’ (<em>n</em> = 16/75; 21%).</p></section><section id="Sec39"><h3 class="pmc_sec_title">Adverse Events</h3>
<p id="Par145">No serious adverse events occurred, with only 10 mild adverse events reported: two on Placebo (both ‘sleepiness’), two on CBD50 (‘headache’ and ‘regurgitation/reflux’) and six on CBD300 (‘sleepiness’ (three reports), ‘sedation’, ‘rash’ and ‘bloating/abdominal pain’).</p></section></section><section id="Sec40"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par146">This study investigated the effects of an acute, low (50 mg) and moderate (300 mg) oral dose of CBD on physiological and subjective responses to exercise in endurance-trained athletes. This represented a more definitive test of the initial results reported in our earlier pilot study [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Contrary to our primary hypothesis, and in contrast to our earlier findings [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>], CBD did not increase positive affect (i.e., FS ratings) during submaximal intensity running. However, in accordance with our secondary hypothesis, CBD had only modest effects on physiological parameters during exercise and no detectable effect on performance (i.e., TTE during an incremental run). These findings indicate that low and moderate doses of CBD are unlikely to have meaningful effects on endurance performance or the experience of exercise in individuals accustomed to running.</p>
<p id="Par147">The discrepancy between the present findings and our earlier study is difficult to explain given that both studies employed very similar methods. In fact, the only major differences between the two studies were the number of treatments investigated and the inclusion of female participants. The addition of a third treatment increased the length of time that participants were involved in the trial and, therefore, the opportunity for their training status to fluctuate. Some preclinical studies have also identified sex differences in the neuropsychiatric effects of CBD [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. However, most participants still completed their treatment sessions within a reasonable timeframe (e.g., 84% within 25 days) and no significant session- or sex-dependent differences in FS ratings were observed. It is also worth noting that participants achieved similar plasma CBD concentrations (i.e., on CBD300) in both studies (present C<sub>max</sub>: 143.3 [94.1–203.6] ng mL<sup>−1</sup>, pilot C<sub>max</sub>: 174 ± 100 ng∙mL<sup>−1</sup>), although high intra-individual variability was observed, as is typically found with CBD [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>].</p>
<p id="Par148">One alternate explanation is that the positive effect observed in the pilot study resulted from a Type 1 Error. Unlike the current investigation, the pilot was not designed nor formally powered to assess “effects” but rather, to determine which outcomes might be worthy of further investigation in a larger, fully powered trial. Outcomes were deemed worthy of further investigation if the 85% confidence interval (CI) around the Cohen’s d<sub><em>z</em></sub> effect of CBD included ± 0.5 but not zero. Thus, the results of the present study, which employed a more robust statistical approach, should take precedence over those of the pilot investigation.</p>
<p id="Par149">Of the two other studies [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>], <a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>] that have investigated the effects of CBD on affective responses to exercise, only one [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>] demonstrated a positive outcome. In that study, CBD-dominant cannabis inhaled ad libitum (~ 94 mg CBD) was found to increase positive affect and exercise enjoyment during a submaximal intensity treadmill run [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. However, it is important to recognise that this treatment also provided a low, but not negligible [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>] dose of THC (~ 3.9 mg), meaning that the effect of CBD, per se, cannot be isolated. The second study administered an oral CBD isolate more comparable to that used in the present investigation and observed no measurable effect on positive affect, nor related metrics (e.g., euphoria, enjoyment)—albeit at a lower dose (150 mg) and in a recreationally active population performing self-paced endurance exercise [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. The present study also demonstrated no effect of CBD on RPE or pain during submaximal intensity exercise, nor on mood or state anxiety after exercise. Taken together, these findings suggest that CBD is unlikely to alter affective responses to exercise, but future research investigating the effects of low doses of THC, alone and/or in combination with CBD (which may modulate its effects [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>, <a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>] may be worthwhile.</p>
<p id="Par150">The present study also investigated the effects of CBD on a broad suite of physiological metrics. Overall, our findings demonstrate very limited effects of CBD on exercise physiology. Neither the 50 nor 300 mg dose altered HR, exercise efficiency (i.e. <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq46"><math id="d33e5866"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub>) or other respiratory parameters during submaximal intensity running; nor did they affect <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq47"><math id="d33e5879"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2peak</sub>. Our findings are broadly consistent with other studies that have previously investigated the effects of CBD on physiological responses to endurance exercise [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>, <a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. Indeed, Gillham et al. [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>] demonstrated no effect of CBD (150 mg day<sup>−1</sup> oral, 8 weeks) on HR during a 10-km cycling time trial, while Cheung et al. [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>] found no effect of CBD (14.5 mg inhaled, acute) on HR, <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq48"><math id="d33e5907"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O<sub>2</sub> or other respiratory parameters during both a 10 min submaximal cycle ergometer test and a 20 min time trial. Additionally, Flores et al. [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>] found no effect of CBD (50 mg day<sup>−1</sup> oral<sub>;</sub> 8 weeks) on <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq49"><math id="d33e5928"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>O2<sub>max</sub> during a modified Astrand treadmill test. Nonetheless, the present study did observe a decrease in RER during submaximal intensity running with CBD (300 mg), and an increase in blood glucose concentration following maximal intensity running with CBD (50 mg) (both compared to Placebo).</p>
<p id="Par151">The first observation suggests that moderate doses of CBD (300 mg) may alter substrate metabolism during submaximal intensity running, increasing lipid and decreasing carbohydrate utilisation (without altering exercise efficiency). This is noteworthy as it has the potential to spare muscle glycogen, which may improve endurance performance [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>]. However, it is important to recognise that the effect was modest (Placebo: 0.94 [0.91–0.97] vs. CBD300: 0.93 [0.90–0.96]) and possibly unlikely to be of practical significance. Indeed, the difference in total carbohydrate oxidation between treatments was estimated to be 2.6 g (i.e., 42 kJ or 0.7 kJ min<sup>−1</sup>) [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. Interestingly, the observed decrease in RER tended to be accompanied by an increase in blood lactate concentration (<em>p</em> = 0.054). These observations are somewhat conflicting given that anaerobic metabolism is typically reduced at lower RERs. However, this effect could be explained by a number of factors (e.g., decreased lactate clearance, enhanced lactate shuttle mechanisms, increased reliance on anaerobic metabolism in specific muscle fibres) [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. There is preclinical evidence to suggest that modulation of the endocannabinoid system (specifically, an agonist action at the cannabinoid 1 receptor) may alter such metabolic processes [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. To our knowledge, however, this has not been reliably demonstrated with CBD administration.</p>
<p id="Par152">The second observation suggests that low doses of CBD (50 mg) may alter carbohydrate metabolism (e.g., stimulate glycogenolysis, stimulate gluconeogenesis, modulate insulin activity) during maximal intensity exercise [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. It is possible that such an effect could occur with altered adrenal responses (e.g., increased release of catecholamines, cortisol, etc.) [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. However, markers of adrenal function were not measured in the present study. Additionally, an elevated cortisol response has only been observed with high intravenous doses of CBD (i.e., 300 mg, 600 mg) [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>], not with lower, oral doses [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. In fact, low doses of CBD are yet to demonstrate marked physiological or metabolic effects [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>].</p>
<p id="Par153">The current study also investigated the effect of CBD on TTE during an incremental (exhaustive) running task to better understand CBD effects on endurance performance. No effect of CBD, at either dose, was observed on TTE. This finding is consistent with studies that have previously investigated the effects of CBD on endurance performance [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>, <a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>–<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. Neither Gillham et al. [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>] nor Cheung et al. [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>] detected an effect of CBD (150 mg day<sup>−1</sup> oral, 8 weeks; 14.5 mg inhaled, acute) on performance during a cycling time trial. Likewise, Isenmann et al. [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>] found no effect of CBD (60 mg day<sup>−1</sup> oral, 6 days) on 1-mile run performance. It is also worth noting that McCartney et al. [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>] demonstrated no effect of CBD on run time during a self-paced 10 km run in recreationally active individuals, although this was not strictly a performance test.</p>
<p id="Par154">Taken collectively, these findings suggest that low to moderate doses of CBD are unlikely to impact endurance performance. As such, the use of CBD in the sporting context, therapeutically or otherwise, appears unlikely to compromise endurance performance. Nonetheless, it is important to recognise that use of CBD by athletes may carry other risks. Firstly, CBD products often contain trace amounts of cannabinoids [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>] that are currently banned by WADA for in-competition use (e.g., cannabigerol). The presence of a minor cannabinoid at any concentration and the detection of 11-COOH-THC at or above a specified threshold (180 ng mL<sup>−1</sup> in urine) constitutes an anti-doping rule violation [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Secondly, there is some evidence to suggest that CBD supplementation (60 mg day<sup>−1</sup>; 6 days) may inhibit exercise-induced liver activity in trained athletes following a high intensity training protocol [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>]. Whether these effects are hepatotoxic remains unknown.</p>
<p id="Par155">Finally, the present study investigated the effects of CBD on markers of muscle damage and GI barrier function. Serum concentrations of creatine kinase and myoglobin were not significantly altered with CBD, nor were subjective ratings of muscle soreness. Most studies investigating the effects of CBD on markers of muscle damage have also demonstrated no effect [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>–<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]; the exception being the study of Isenmann et al. [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], which reported that CBD (60 mg oral; acute) decreased blood serum concentrations of creatine kinase and myoglobin at 72 h, but not 24 or 48 h, following resistance exercise. In any case, the present findings should be interpreted with caution as the exercise protocol employed in the current investigation was not designed to elicit extensive muscle damage. It is also possible that the post-exercise period was too short to capture peak creatine kinase and myoglobin concentrations, which have been demonstrated to occur between 4–24 h [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>] and 2–3 h [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>] following similar (non-eccentric) treadmill-based exercise intervention, respectively.</p>
<p id="Par156">Regarding GI barrier function, the present study demonstrated an effect of CBD (50 mg) to increase serum concentrations of LPS, specifically in female participants following maximal intensity exercise. LPS is a component of the bacterial cell membrane and a marker of intestinal permeability that often becomes elevated with intense or prolonged exercise [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>], particularly with heat stress and dehydration [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>, <a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. It is unclear why the lower dose of CBD affected this marker in female participants only. However, it may be important to note that there was a high level of inter-individual variation in LPS concentrations, and the number of female participants was small (<em>n</em> = 9). CBD also appeared to affect GI comfort; 50 mg increased ratings of regurgitation, while 300 mg increased ratings of belching, compared to placebo. GI symptoms are among the most frequently reported adverse effects of CBD [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>, <a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. However, the differences observed here should be interpreted with caution as they were inclusive of (i.e., present at) baseline.</p>
<p id="Par157">This study provides a highly controlled assessment of the influence of CBD on subjective and physiological responses to exercise. However, it is not without limitations. First, due to the large number of outcomes assessed, there is an increased probability of detecting significant effects by chance (i.e., Type 1 Error). Second, plasma CBD concentrations varied considerably between participants; although, it is worth noting that this is common following oral CBD administration [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Third, it is also likely that plasma CBD concentrations were low during the early stages of RUN 1. Although it should be recognised that all participants reached their C<sub>max</sub> within the exercise period (i.e. Pre Run 1 to Post RUN 2). Fourth, the age range of the population was relatively wide (19–44 years), potentially introducing variability. Fifth, the number of male and female participants was unbalanced. Finally, while the present study has demonstrated minimal effects of CBD on responses to exercise in a healthy, endurance-trained population, it is important to recognise that different effects may be observed in populations with clinical conditions (i.e., in which CBD may have disease modifying effects) and in athletic populations with certain conditions (e.g., training and/or performance anxiety).</p></section><section id="Sec41"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par158">This study demonstrates that acute low (50 mg) and moderate (300 mg) doses of CBD do not alter the subjective experience of submaximal endurance exercise (i.e. affect, enjoyment, pain or perceived exertion), have limited effect on physiological responses to exercise, and have no detectable effect on endurance performance. Use of CBD by athletes is, therefore, not likely to be ergolytic nor ergogenic at low to moderate doses.</p></section><section id="Sec42"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12370602/bin/40798_2025_895_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (357.9KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We would like to extend our sincerest gratitude to all participants for their commitment and contribution to this study.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>7-COOH-CBD</dt>
<dd><p id="Par9">7-Carboxycannabidiol</p></dd>
<dt>7-OH-CBD</dt>
<dd><p id="Par10">7-Hydroxycannabidiol</p></dd>
<dt>6-OH-CBD</dt>
<dd><p id="Par11">6-Hydroxycannabidiol</p></dd>
<dt>11-COOH-THC</dt>
<dd><p id="Par12">11-Carboxytetrahydrocannabinol</p></dd>
<dt>11-OH-THC</dt>
<dd><p id="Par13">11-Hydroxytetrahydrocannabinol</p></dd>
<dt>CBD</dt>
<dd><p id="Par14">Cannabidiol</p></dd>
<dt>CBD50</dt>
<dd><p id="Par15">50 Mg cannabidiol</p></dd>
<dt>CBD300</dt>
<dd><p id="Par16">300 Mg cannabidiol</p></dd>
<dt>CBDV</dt>
<dd><p id="Par17">Cannabidivarin</p></dd>
<dt>CI</dt>
<dd><p id="Par18">Confidence interval</p></dd>
<dt>CK</dt>
<dd><p id="Par19">Creatine kinase</p></dd>
<dt>FDA</dt>
<dd><p id="Par20">Food and Drug Administration</p></dd>
<dt>FS</dt>
<dd><p id="Par21">Feelings Scale</p></dd>
<dt>GI</dt>
<dd><p id="Par22">Gastrointestinal</p></dd>
<dt>HR</dt>
<dd><p id="Par23">Heart rate</p></dd>
<dt>HR<sub>max</sub>
</dt>
<dd><p id="Par24">Maximal heart rate</p></dd>
<dt>HR<sub>peak</sub>
</dt>
<dd><p id="Par25">Peak heart rate</p></dd>
<dt>IQR</dt>
<dd><p id="Par26">Interquartile range</p></dd>
<dt>LAL</dt>
<dd><p id="Par27">Limulus amebocyte lysate</p></dd>
<dt>LLOQ</dt>
<dd><p id="Par28">Lower limit of quantification</p></dd>
<dt>LPS</dt>
<dd><p id="Par29">Lipopolysaccharide</p></dd>
<dt>MCT</dt>
<dd><p id="Par30">Medium chain triglyceride oil</p></dd>
<dt>Myo</dt>
<dd><p id="Par31">Myoglobin</p></dd>
<dt>PACES</dt>
<dd><p id="Par32">Physical Activity Enjoyment Scale</p></dd>
<dt>POMS</dt>
<dd><p id="Par33">Profile of Mood States</p></dd>
<dt>RER</dt>
<dd><p id="Par34">Respiratory exchange ratio</p></dd>
<dt>RERpeak</dt>
<dd><p id="Par35">Peak respiratory exchange ratio</p></dd>
<dt>RR</dt>
<dd><p id="Par36">Respiratory rate</p></dd>
<dt>RR<sub>peak</sub>
</dt>
<dd><p id="Par37">Peak respiratory rate</p></dd>
<dt>RUN 1</dt>
<dd><p id="Par38">Submaximal treadmill run</p></dd>
<dt>RUN 2</dt>
<dd><p id="Par39">Incremental (maximal) treadmill run</p></dd>
<dt>SD</dt>
<dd><p id="Par40">Standard deviation</p></dd>
<dt>S-PACES</dt>
<dd><p id="Par41">Short-form Physical Activity Enjoyment Scale</p></dd>
<dt>STAI-S</dt>
<dd><p id="Par42">Short-form State-Trait Anxiety Inventory</p></dd>
<dt>THC</dt>
<dd><p id="Par43">Δ9-Tetrahydrocannabinol</p></dd>
<dt>TTE</dt>
<dd><p id="Par44">Time to exhaustion</p></dd>
<dt>UDS</dt>
<dd><p id="Par45">Urine drug screen</p></dd>
<dt>USG</dt>
<dd><p id="Par46">Urine specific gravity</p></dd>
<dt>VAS</dt>
<dd><p id="Par47">Visual Analogue Scale</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq400"><math id="d33e628"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙CO2</dt>
<dd><p id="Par48">Rate of carbon dioxide production</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq401"><math id="d33e644"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙CO2peak</dt>
<dd><p id="Par49">Peak rate of carbon dioxide production</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq402"><math id="d33e660"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙E</dt>
<dd><p id="Par50">Minute ventilation</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq403"><math id="d33e676"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙E<sub>peak</sub>
</dt>
<dd><p id="Par51">Peak minute ventilation</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq404"><math id="d33e693"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙O2</dt>
<dd><p id="Par52">Rate of oxygen consumption</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq405"><math id="d33e710"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙O2<sub>max</sub>
</dt>
<dd><p id="Par53">Maximal rate of oxygen consumption</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq406"><math id="d33e727"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙O2<sub>peak</sub>
</dt>
<dd><p id="Par54">Peak rate of oxygen consumption</p></dd>
<dt>
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq407"><math id="d33e744"><mover accent="true"><mtext>V</mtext><mo>˙</mo></mover></math></span>˙O2<sub>peak</sub>
</dt>
<dd><p id="Par55">Peak rate of oxygen consumption</p></dd>
<dt>VT</dt>
<dd><p id="Par56">Tidal volume</p></dd>
<dt>V<sub>Tpeak</sub>
</dt>
<dd><p id="Par57">Peak tidal volume</p></dd>
<dt>WADA</dt>
<dd><p id="Par58">World Anti-Doping Agency</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>A.S., A.S., C.I., A.J.C., B.D., N.J., P.A., P.H., I.S.M. and D.M. contributed to the conception and design of the study. A.S., N.L., A.S. and D.M. were involved in data collection. R.G., A.J.C., K.W. were involved in the analysis of biological samples. A.S. and D.M. completed data analysis and drafted the original manuscript. All authors were involved in critically revising the manuscript and approved the final submitted version.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was funded by the Lambert Initiative for Cannabinoid Therapeutics, a philanthropically funded centre for medicinal cannabis research at the University of Sydney. The philanthropic donor did not have any input into the investigation.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data Availability</h2>
<p>The deidentified participant data are available from Ms Ayshe Sahinovic upon reasonable request (ayshe.sahinovic@sydney.edu.au).</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics Approval and Consent to Participate</h3>
<p id="Par1510">This study was approved by the Sydney Local Health District’s Human Research Ethics Committee (2021/ <a href="https://www.ncbi.nlm.nih.gov/protein/ETH11945" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ETH11945</a>; X21-0392), registered prospectively with the Australia and New Zealand Clinical Trials Registry (ACTRN12622000717752) on 19th May, 2022 and conducted in accordance with the standards of ethics outlined in the Declaration of Helsinki. All participants provided written informed consent prior to enrolment.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for Publication</h3>
<p id="Par1534">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par1545">A.S., R.G., K.W., I.S.M., and D.M. receive salary support from the Lambert Initiative for Cannabinoid Therapeutics. I.S.M. and D.M. has received consulting fees from Medicinal Cannabis Industry Australia (MCIA). I.S.M. has also received consulting fees Kinoxis Therapeutics and Janssen. I.S.M. and D.M. have served as expert witnesses in medicolegal cases involving cannabis and cannabinoids. I.S.M is also named as an inventor on several patents relating to novel cannabinoid therapeutics (PCT/AU2018/05089 and PCT/AU2019/050554).</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Ayshe Sahinovic, Email: ayshe.sahinovic@sydney.edu.au.</p>
<p>Danielle McCartney, Email: danielle.mccartney@sydney.edu.au.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Hanus LO, et al. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357–92.
</cite> [<a href="https://doi.org/10.1039/c6np00074f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27722705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hanus%20LO,%20et%20al.%20Phytocannabinoids:%20a%20unified%20critical%20inventory.%20Nat%20Prod%20Rep.%202016;33(12):1357%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>McCartney D, et al. The effect of cannabidiol on simulated car driving performance: a randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol. Hum Psychopharmacol Clin Exp. 2020;35(5): e2749.</cite> [<a href="https://doi.org/10.1002/hup.2749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32729120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCartney%20D,%20et%20al.%20The%20effect%20of%20cannabidiol%20on%20simulated%20car%20driving%20performance:%20a%20randomised,%20double-blind,%20placebo-controlled,%20crossover,%20dose-ranging%20clinical%20trial%20protocol.%20Hum%20Psychopharmacol%20Clin%20Exp.%202020;35(5):%20e2749." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Spindle TR, et al. Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial. JAMA Netw Open. 2018;1(7): e184841.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2018.4841" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30646391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindle%20TR,%20et%20al.%20Acute%20effects%20of%20smoked%20and%20vaporized%20cannabis%20in%20healthy%20adults%20who%20infrequently%20use%20cannabis:%20a%20crossover%20trial.%20JAMA%20Netw%20Open.%202018;1(7):%20e184841." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Spindle TR, et al. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend. 2020;211: 107937.
</cite> [<a href="https://doi.org/10.1016/j.drugalcdep.2020.107937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7414803/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32247649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindle%20TR,%20et%20al.%20Pharmacodynamic%20effects%20of%20vaporized%20and%20oral%20cannabidiol%20(CBD)%20and%20vaporized%20CBD-dominant%20cannabis%20in%20infrequent%20cannabis%20users.%20Drug%20Alcohol%20Depend.%202020;211:%20107937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238(1):9–28.
</cite> [<a href="https://doi.org/10.1007/s00213-020-05712-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7796924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33221931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Britch%20SC,%20Babalonis%20S,%20Walsh%20SL.%20Cannabidiol:%20pharmacology%20and%20therapeutic%20targets.%20Psychopharmacology.%202021;238(1):9%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Thiele E, et al. Cannabidiol in patients with Lennox-Gastaut syndrome: interim analysis of an open-label extension study. Epilepsia. 2019;60(3):419–28.
</cite> [<a href="https://doi.org/10.1111/epi.14670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6850399/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30740695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thiele%20E,%20et%20al.%20Cannabidiol%20in%20patients%20with%20Lennox-Gastaut%20syndrome:%20interim%20analysis%20of%20an%20open-label%20extension%20study.%20Epilepsia.%202019;60(3):419%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Devinsky O, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888–97.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1714631" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29768152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Devinsky%20O,%20et%20al.%20Effect%20of%20cannabidiol%20on%20drop%20seizures%20in%20the%20Lennox-Gastaut%20syndrome.%20N%20Engl%20J%20Med.%202018;378(20):1888%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Devinsky O, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011–20.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1611618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28538134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Devinsky%20O,%20et%20al.%20Trial%20of%20cannabidiol%20for%20drug-resistant%20seizures%20in%20the%20Dravet%20syndrome.%20N%20Engl%20J%20Med.%202017;376(21):2011%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>U.S.-Food-and-Drug-Administration-Center-for-Drug-Evaluation-and-Research. <em>Epidiolex NDA 210365 Approval Letter</em>. June 25, 2018 [cited 2021 30th March]; Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000Approv.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210365Orig1s000Approv.pdf</a>.</cite>
</li>
<li id="CR10">
<span class="label">10.</span><cite>Berger M, et al. Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial. J Clin Psychiatry. 2022;83: 21m14130. 10.4088/jcp.21m14130.
</cite> [<a href="https://doi.org/10.4088/JCP.21m14130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35921510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berger%20M,%20et%20al.%20Cannabidiol%20for%20treatment-resistant%20anxiety%20disorders%20in%20young%20people:%20an%20open-label%20trial.%20J%20Clin%20Psychiatry.%202022;83:%2021m14130.%2010.4088/jcp.21m14130." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219–26.
</cite> [<a href="https://doi.org/10.1038/npp.2011.6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3079847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21307846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bergamaschi%20MM,%20et%20al.%20Cannabidiol%20reduces%20the%20anxiety%20induced%20by%20simulated%20public%20speaking%20in%20treatment-naive%20social%20phobia%20patients.%20Neuropsychopharmacology.%202011;36(6):1219%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Front Psychol. 2019;10.</cite> [<a href="https://doi.org/10.3389/fpsyg.2019.02466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6856203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31787910/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>McCartney D, et al. Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research. Sports Med Open. 2020;6(1):27.
</cite> [<a href="https://doi.org/10.1186/s40798-020-00251-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7338332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32632671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCartney%20D,%20et%20al.%20Cannabidiol%20and%20sports%20performance:%20a%20narrative%20review%20of%20relevant%20evidence%20and%20recommendations%20for%20future%20research.%20Sports%20Med%20Open.%202020;6(1):27." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Millar SA, et al. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018. 10.3389/fphar.2018.01365.
</cite> [<a href="https://doi.org/10.3389/fphar.2018.01365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6275223/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30534073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Millar%20SA,%20et%20al.%20A%20systematic%20review%20on%20the%20pharmacokinetics%20of%20cannabidiol%20in%20humans.%20Front%20Pharmacol.%202018.%2010.3389/fphar.2018.01365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Leas EC, et al. Trends in internet searches for cannabidiol (CBD) in the United States. JAMA Netw Open. 2019;2(10):e1913853.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2019.13853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6820034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31642924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leas%20EC,%20et%20al.%20Trends%20in%20internet%20searches%20for%20cannabidiol%20(CBD)%20in%20the%20United%20States.%20JAMA%20Netw%20Open.%202019;2(10):e1913853." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Arnold JC, et al. The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence. Clin Transl Sci. 2023;16(1):10–30.
</cite> [<a href="https://doi.org/10.1111/cts.13425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9841308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36259271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arnold%20JC,%20et%20al.%20The%20safety%20and%20efficacy%20of%20low%20oral%20doses%20of%20cannabidiol:%20an%20evaluation%20of%20the%20evidence.%20Clin%20Transl%20Sci.%202023;16(1):10%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Zeiger JS, et al. Cannabis use in active athletes: behaviors related to subjective effects. PLoS ONE. 2019;14(6):e0218998–e0218998.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0218998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6598761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31251769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zeiger%20JS,%20et%20al.%20Cannabis%20use%20in%20active%20athletes:%20behaviors%20related%20to%20subjective%20effects.%20PLoS%20ONE.%202019;14(6):e0218998%E2%80%93e0218998." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Kasper AM, et al. High prevalence of cannabidiol use within male professional rugby union and league players: a quest for pain relief and enhanced recovery. Int J Sport Nutr Exerc Metab. 2020;30(5):315–22.
</cite> [<a href="https://doi.org/10.1123/ijsnem.2020-0151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32732454/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kasper%20AM,%20et%20al.%20High%20prevalence%20of%20cannabidiol%20use%20within%20male%20professional%20rugby%20union%20and%20league%20players:%20a%20quest%20for%20pain%20relief%20and%20enhanced%20recovery.%20Int%20J%20Sport%20Nutr%20Exerc%20Metab.%202020;30(5):315%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>World-Anti-Doping-Agency. Summary of Major Modifications and Explanatory Notes. 2018 30 March 2021]; Available from: <a href="https://www.wada-ama.org/sites/default/files/prohibited_list_2018_summary_of_modifications_en.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.wada-ama.org/sites/default/files/prohibited_list_2018_summary_of_modifications_en.pdf</a>.</cite>
</li>
<li id="CR20">
<span class="label">20.</span><cite>McGregor IS, et al. Access to cannabidiol without a prescription: a cross-country comparison and analysis. Int J Drug Policy. 2020;85: 102935.
</cite> [<a href="https://doi.org/10.1016/j.drugpo.2020.102935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32919298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McGregor%20IS,%20et%20al.%20Access%20to%20cannabidiol%20without%20a%20prescription:%20a%20cross-country%20comparison%20and%20analysis.%20Int%20J%20Drug%20Policy.%202020;85:%20102935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Crossland BW, et al. Acute supplementation with cannabidiol does not attenuate inflammation or improve measures of performance following strenuous exercise. Healthcare. 2022. 10.3390/healthcare10061133.
</cite> [<a href="https://doi.org/10.3390/healthcare10061133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9222918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35742183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crossland%20BW,%20et%20al.%20Acute%20supplementation%20with%20cannabidiol%20does%20not%20attenuate%20inflammation%20or%20improve%20measures%20of%20performance%20following%20strenuous%20exercise.%20Healthcare.%202022.%2010.3390/healthcare10061133." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Cochrane-Snyman KC, et al. The effects of cannabidiol oil on noninvasive measures of muscle damage in men. Med Sci Sports Exerc. 2021;53(7):1460–72.
</cite> [<a href="https://doi.org/10.1249/MSS.0000000000002606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33481484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cochrane-Snyman%20KC,%20et%20al.%20The%20effects%20of%20cannabidiol%20oil%20on%20noninvasive%20measures%20of%20muscle%20damage%20in%20men.%20Med%20Sci%20Sports%20Exerc.%202021;53(7):1460%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Isenmann E, et al. Effects of cannabidiol supplementation on skeletal muscle regeneration after intensive resistance training. Nutrients. 2021. 10.3390/nu13093028.
</cite> [<a href="https://doi.org/10.3390/nu13093028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8469280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34578906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Isenmann%20E,%20et%20al.%20Effects%20of%20cannabidiol%20supplementation%20on%20skeletal%20muscle%20regeneration%20after%20intensive%20resistance%20training.%20Nutrients.%202021.%2010.3390/nu13093028." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Hatchett AA, Hughes B, Parr B. The influence cannabidiol on delayed onset of muscle soreness. Int J Phys Educ Sports Health. 2020;7:89–94.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hatchett%20AA,%20Hughes%20B,%20Parr%20B.%20The%20influence%20cannabidiol%20on%20delayed%20onset%20of%20muscle%20soreness.%20Int%20J%20Phys%20Educ%20Sports%20Health.%202020;7:89%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Isenmann E, et al. Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study. J Int Soc Sports Nutr. 2024;21(1): 2337252.
</cite> [<a href="https://doi.org/10.1080/15502783.2024.2337252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10997358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Isenmann%20E,%20et%20al.%20Influence%20of%20short-term%20chronic%20oral%20cannabidiol%20application%20on%20muscle%20recovery%20and%20performance%20after%20an%20intensive%20training%20protocol%20-%20a%20randomized%20double-blind%20crossover%20study.%20J%20Int%20Soc%20Sports%20Nutr.%202024;21(1):%202337252." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Peters EN, et al. A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS). J Int Soc Sports Nutr. 2023;20(1): 2280113.
</cite> [<a href="https://doi.org/10.1080/15502783.2023.2280113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10653658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37947792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peters%20EN,%20et%20al.%20A%20randomized,%20double-blind,%20placebo-controlled,%20repeated-dose%20pilot%20study%20of%20the%20safety,%20tolerability,%20and%20preliminary%20effects%20of%20a%20cannabidiol%20(CBD)-%20and%20cannabigerol%20(CBG)-based%20beverage%20powder%20to%20support%20recovery%20from%20delayed%20onset%20muscle%20soreness%20(DOMS).%20J%20Int%20Soc%20Sports%20Nutr.%202023;20(1):%202280113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Alpy A, et al. Topical cannabidiol and the progression rate of delayed onset muscle soreness. Int J Exerc Sci. 2023;16(3):1426–39.
</cite> [<a href="https://doi.org/10.70252/KAGH6991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10824304/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38287971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alpy%20A,%20et%20al.%20Topical%20cannabidiol%20and%20the%20progression%20rate%20of%20delayed%20onset%20muscle%20soreness.%20Int%20J%20Exerc%20Sci.%202023;16(3):1426%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Pastina JT, et al. Topical cannabidiol application may not attenuate muscle soreness or improve performance: a randomized, double-blinded, placebo-controlled pilot study. Cannabis and Cannabinoid Research. 2024.</cite> [<a href="https://doi.org/10.1089/can.2024.0012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38980809/" class="usa-link">PubMed</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Stone WJ, et al. A pilot study on cannabidiol (CBD) and eccentric exercise: impact on inflammation, performance, and pain. Int J Exerc Sci. 2023;16(2):109–17.
</cite> [<a href="https://doi.org/10.70252/VWUK7519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10124724/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37114193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stone%20WJ,%20et%20al.%20A%20pilot%20study%20on%20cannabidiol%20(CBD)%20and%20eccentric%20exercise:%20impact%20on%20inflammation,%20performance,%20and%20pain.%20Int%20J%20Exerc%20Sci.%202023;16(2):109%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Sahinovic A, et al. Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial. Sports Med Open. 2022;8(1):27.
</cite> [<a href="https://doi.org/10.1186/s40798-022-00417-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8891421/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35235092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sahinovic%20A,%20et%20al.%20Effects%20of%20cannabidiol%20on%20exercise%20physiology%20and%20bioenergetics:%20a%20randomised%20controlled%20pilot%20trial.%20Sports%20Med%20Open.%202022;8(1):27." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Lane AM, et al. Emotional intelligence and emotions associated with optimal and dysfunctional athletic performance. J Sports Sci Med. 2010;9(3):388–92.
</cite> [<a href="/articles/PMC3761705/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24149631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lane%20AM,%20et%20al.%20Emotional%20intelligence%20and%20emotions%20associated%20with%20optimal%20and%20dysfunctional%20athletic%20performance.%20J%20Sports%20Sci%20Med.%202010;9(3):388%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Samełko A, Guszkowska M, Gala-Kwiatkowska A. Affective states influence sport performance in swimming. Pol J Sport Tourism. 2018;25(4):21–6.</cite> [<a href="https://scholar.google.com/scholar_lookup?Same%C5%82ko%20A,%20Guszkowska%20M,%20Gala-Kwiatkowska%20A.%20Affective%20states%20influence%20sport%20performance%20in%20swimming.%20Pol%20J%20Sport%20Tourism.%202018;25(4):21%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Perkins D, Wilson GV, Kerr JH. The effects of elevated arousal and mood on maximal strength performance in athletes. J Appl Sport Psychol. 2001;13(3):239–59.</cite> [<a href="https://scholar.google.com/scholar_lookup?Perkins%20D,%20Wilson%20GV,%20Kerr%20JH.%20The%20effects%20of%20elevated%20arousal%20and%20mood%20on%20maximal%20strength%20performance%20in%20athletes.%20J%20Appl%20Sport%20Psychol.%202001;13(3):239%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Jekauc D. Enjoyment during exercise mediates the effects of an intervention on exercise adherence. Psychology. 2015;6(1):48–54.</cite> [<a href="https://scholar.google.com/scholar_lookup?Jekauc%20D.%20Enjoyment%20during%20exercise%20mediates%20the%20effects%20of%20an%20intervention%20on%20exercise%20adherence.%20Psychology.%202015;6(1):48%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Teixeira PJ, et al. Exercise, physical activity, and self-determination theory: a systematic review. Int J Behav Nutr Phys Act. 2012;9(1):78.
</cite> [<a href="https://doi.org/10.1186/1479-5868-9-78" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3441783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22726453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teixeira%20PJ,%20et%20al.%20Exercise,%20physical%20activity,%20and%20self-determination%20theory:%20a%20systematic%20review.%20Int%20J%20Behav%20Nutr%20Phys%20Act.%202012;9(1):78." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Lewis BA, et al. Self-efficacy versus perceived enjoyment as predictors of physical activity behaviour. Psychol Health. 2016;31(4):456–69.
</cite> [<a href="https://doi.org/10.1080/08870446.2015.1111372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4769927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26541890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lewis%20BA,%20et%20al.%20Self-efficacy%20versus%20perceived%20enjoyment%20as%20predictors%20of%20physical%20activity%20behaviour.%20Psychol%20Health.%202016;31(4):456%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Jones AM. The fourth dimension: physiological resilience as an independent determinant of endurance exercise performance. J Physiol. 2024;602(17):4113–28.
</cite> [<a href="https://doi.org/10.1113/JP284205" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37606604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jones%20AM.%20The%20fourth%20dimension:%20physiological%20resilience%20as%20an%20independent%20determinant%20of%20endurance%20exercise%20performance.%20J%20Physiol.%202024;602(17):4113%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Joyner MJ. Modeling: optimal marathon performance on the basis of physiological factors. J Appl Physiol. 1985;70(2):683–7.</cite> [<a href="https://doi.org/10.1152/jappl.1991.70.2.683" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2022559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Joyner%20MJ.%20Modeling:%20optimal%20marathon%20performance%20on%20the%20basis%20of%20physiological%20factors.%20J%20Appl%20Physiol.%201985;70(2):683%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Balke B, Ware RW. An experimental study of physical fitness of Air Force personnel. US Armed Forces Med J. 1959;10(6):675–88.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/13659732/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balke%20B,%20Ware%20RW.%20An%20experimental%20study%20of%20physical%20fitness%20of%20Air%20Force%20personnel.%20US%20Armed%20Forces%20Med%20J.%201959;10(6):675%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Armstrong LE, et al. Human hydration indices: acute and longitudinal reference values. Int J Sport Nutr Exerc Metab. 2010;20(2):145–53.
</cite> [<a href="https://doi.org/10.1123/ijsnem.20.2.145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20479488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Armstrong%20LE,%20et%20al.%20Human%20hydration%20indices:%20acute%20and%20longitudinal%20reference%20values.%20Int%20J%20Sport%20Nutr%20Exerc%20Metab.%202010;20(2):145%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Suraev A, et al. Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open. 2020;10(5): e034421.
</cite> [<a href="https://doi.org/10.1136/bmjopen-2019-034421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7239553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32430450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suraev%20A,%20et%20al.%20Cannabidiol%20(CBD)%20and%20%CE%949-tetrahydrocannabinol%20(THC)%20for%20chronic%20insomnia%20disorder%20(%E2%80%98CANSLEEP%E2%80%99%20trial):%20protocol%20for%20a%20randomised,%20placebo-controlled,%20double-blinded,%20proof-of-concept%20trial.%20BMJ%20Open.%202020;10(5):%20e034421." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Coyle EF, González-Alonso J. Cardiovascular drift during prolonged exercise: new perspectives. Exerc Sport Sci Rev. 2001;29(2):88–92.
</cite> [<a href="https://doi.org/10.1097/00003677-200104000-00009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11337829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coyle%20EF,%20Gonz%C3%A1lez-Alonso%20J.%20Cardiovascular%20drift%20during%20prolonged%20exercise:%20new%20perspectives.%20Exerc%20Sport%20Sci%20Rev.%202001;29(2):88%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Hardy CJ, Rejeski WJ. Not what, but how one feels: the measurement of affect during exercise. J Sport Exerc Psychol. 1989;11(3):304–17.</cite> [<a href="https://scholar.google.com/scholar_lookup?Hardy%20CJ,%20Rejeski%20WJ.%20Not%20what,%20but%20how%20one%20feels:%20the%20measurement%20of%20affect%20during%20exercise.%20J%20Sport%20Exerc%20Psychol.%201989;11(3):304%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Teques P, et al. Validation and adaptation of the physical activity enjoyment scale (PACES) in fitness group exercisers. J Sport Health Sci. 2020;9(4):352–7.
</cite> [<a href="https://doi.org/10.1016/j.jshs.2017.09.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7411091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32768128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teques%20P,%20et%20al.%20Validation%20and%20adaptation%20of%20the%20physical%20activity%20enjoyment%20scale%20(PACES)%20in%20fitness%20group%20exercisers.%20J%20Sport%20Health%20Sci.%202020;9(4):352%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Borg G. Borg's perceived exertion and pain scales. Champaign, IL: Human Kinetics. viii, 104. 1998.</cite>
</li>
<li id="CR46">
<span class="label">46.</span><cite>Kendzierski D, DeCarlo KJ. Physical activity enjoyment scale: two validation studies. J Sport Exerc Psychol. 1991. 10.1123/jsep.13.1.50.</cite> [<a href="https://scholar.google.com/scholar_lookup?Kendzierski%20D,%20DeCarlo%20KJ.%20Physical%20activity%20enjoyment%20scale:%20two%20validation%20studies.%20J%20Sport%20Exerc%20Psychol.%201991.%2010.1123/jsep.13.1.50." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Marteau T, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31:301–6.
</cite> [<a href="https://doi.org/10.1111/j.2044-8260.1992.tb00997.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1393159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marteau%20T,%20Bekker%20H.%20The%20development%20of%20a%20six-item%20short-form%20of%20the%20state%20scale%20of%20the%20Spielberger%20State-Trait%20Anxiety%20Inventory%20(STAI).%20Br%20J%20Clin%20Psychol.%201992;31:301%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Bailey SJ, et al. Dietary nitrate supplementation reduces the O-2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107(4):1144–55.
</cite> [<a href="https://doi.org/10.1152/japplphysiol.00722.2009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19661447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bailey%20SJ,%20et%20al.%20Dietary%20nitrate%20supplementation%20reduces%20the%20O-2%20cost%20of%20low-intensity%20exercise%20and%20enhances%20tolerance%20to%20high-intensity%20exercise%20in%20humans.%20J%20Appl%20Physiol.%202009;107(4):1144%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Shacham S. A shortened version of the profile of mood states. J Pers Assess. 1983;47(3):305–6.
</cite> [<a href="https://doi.org/10.1207/s15327752jpa4703_14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6886962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shacham%20S.%20A%20shortened%20version%20of%20the%20profile%20of%20mood%20states.%20J%20Pers%20Assess.%201983;47(3):305%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Kevin RC, et al. A validated method for the simultaneous quantification of CBD, THC, and their metabolites in human plasma, and application to plasma samples from an oral CBD open label trial. Drug Test Anal. 2020.</cite> [<a href="https://doi.org/10.1002/dta.2947" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33095968/" class="usa-link">PubMed</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Griffin SE, Robergs RA, Heyward VH. Blood pressure measurement during exercise: a review. Med Sci Sports Exerc. 1997;29(1):149–59.
</cite> [<a href="https://doi.org/10.1097/00005768-199701000-00022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9000169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Griffin%20SE,%20Robergs%20RA,%20Heyward%20VH.%20Blood%20pressure%20measurement%20during%20exercise:%20a%20review.%20Med%20Sci%20Sports%20Exerc.%201997;29(1):149%E2%80%9359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Core Team R. R: A language and environment for statistical computing. Foundation for Statistical Computing, Vienna, Austria. 2013.</cite>
</li>
<li id="CR53">
<span class="label">53.</span><cite>Bates D, et al. Fitting linear mixed-effects models using the lme4 package in R. J Stat Softw. 2014;67:1–48.</cite> [<a href="https://scholar.google.com/scholar_lookup?Bates%20D,%20et%20al.%20Fitting%20linear%20mixed-effects%20models%20using%20the%20lme4%20package%20in%20R.%20J%20Stat%20Softw.%202014;67:1%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13).</cite>
</li>
<li id="CR55">
<span class="label">55.</span><cite>Christensen R. ordinal—Regression Models for Ordinal Data. R package version 2023.12-4.1. 2023.</cite>
</li>
<li id="CR56">
<span class="label">56.</span><cite>Herve M. RVAideMemoire: testing and plotting procedures for biostatistics. R package version 0.9-83-2, 2023. 2023.</cite>
</li>
<li id="CR57">
<span class="label">57.</span><cite>Lenth R. emmeans: Estimated marginal means, aka least-squares means. R package version 1.7.4-1, 2022. 2022.</cite>
</li>
<li id="CR58">
<span class="label">58.</span><cite>Fox JW. An {R} Companion to applied regression. 3rd edn. 2019. Thousand Oaks CA: Sage.</cite>
</li>
<li id="CR59">
<span class="label">59.</span><cite>Bartoń K. MuMIn: multi-model inference. R package version 1.46.0, 2022.</cite>
</li>
<li id="CR60">
<span class="label">60.</span><cite>Wickham H. Data analysis. New York: Springer; 2016.</cite> [<a href="https://scholar.google.com/scholar_lookup?Wickham%20H.%20Data%20analysis.%20New%20York:%20Springer;%202016." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Ujváry I, Hanuš L. Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy. Cannabis Cannabinoid Res. 2016;1(1):90–101.
</cite> [<a href="https://doi.org/10.1089/can.2015.0012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5576600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28861484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ujv%C3%A1ry%20I,%20Hanu%C5%A1%20L.%20Human%20metabolites%20of%20cannabidiol:%20a%20review%20on%20their%20formation,%20biological%20activity,%20and%20relevance%20in%20therapy.%20Cannabis%20Cannabinoid%20Res.%202016;1(1):90%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Matheson J, Bourgault Z, Le Foll B. Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: a scoping review. Biomolecules. 2022. 10.3390/biom12101462.
</cite> [<a href="https://doi.org/10.3390/biom12101462" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9599539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36291671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matheson%20J,%20Bourgault%20Z,%20Le%20Foll%20B.%20Sex%20differences%20in%20the%20neuropsychiatric%20effects%20and%20pharmacokinetics%20of%20cannabidiol:%20a%20scoping%20review.%20Biomolecules.%202022.%2010.3390/biom12101462." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Taylor L, et al. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32(11):1053–67.
</cite> [<a href="https://doi.org/10.1007/s40263-018-0578-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6223703/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30374683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Taylor%20L,%20et%20al.%20A%20phase%20I,%20randomized,%20double-blind,%20placebo-controlled,%20single%20ascending%20dose,%20multiple%20dose,%20and%20food%20effect%20trial%20of%20the%20safety,%20tolerability%20and%20pharmacokinetics%20of%20highly%20purified%20cannabidiol%20in%20healthy%20subjects.%20CNS%20Drugs.%202018;32(11):1053%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Gibson LP, et al. Acute effects of ad libitum use of commercially available cannabis products on the subjective experience of aerobic exercise: a crossover study. Sports Med. 2024;54(4):1051–66.
</cite> [<a href="https://doi.org/10.1007/s40279-023-01980-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38147185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gibson%20LP,%20et%20al.%20Acute%20effects%20of%20ad%20libitum%20use%20of%20commercially%20available%20cannabis%20products%20on%20the%20subjective%20experience%20of%20aerobic%20exercise:%20a%20crossover%20study.%20Sports%20Med.%202024;54(4):1051%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>McCartney D, et al. The effect of cannabidiol on subjective responses to endurance exercise: a randomised controlled trial. Sports Medicine - Open. 2024;10(1):61.
</cite> [<a href="https://doi.org/10.1186/s40798-024-00727-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11116295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38782848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCartney%20D,%20et%20al.%20The%20effect%20of%20cannabidiol%20on%20subjective%20responses%20to%20endurance%20exercise:%20a%20randomised%20controlled%20trial.%20Sports%20Medicine%20-%20Open.%202024;10(1):61." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Drennan ML, et al. Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates. Sci Rep. 2021;11(1):21744.
</cite> [<a href="https://doi.org/10.1038/s41598-021-01128-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8571303/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34741088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drennan%20ML,%20et%20al.%20Acute%20objective%20and%20subjective%20intoxication%20effects%20of%20legal-market%20high%20potency%20THC-dominant%20versus%20CBD-dominant%20cannabis%20concentrates.%20Sci%20Rep.%202021;11(1):21744." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Arkell TR, et al. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Psychopharmacology. 2019;236(9):2713–24.
</cite> [<a href="https://doi.org/10.1007/s00213-019-05246-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6695367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31044290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arkell%20TR,%20et%20al.%20Cannabidiol%20(CBD)%20content%20in%20vaporized%20cannabis%20does%20not%20prevent%20tetrahydrocannabinol%20(THC)-induced%20impairment%20of%20driving%20and%20cognition.%20Psychopharmacology.%202019;236(9):2713%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Chung H, Fierro A, Pessoa-Mahana CD. Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: an in silico study. PLoS ONE. 2019;14(7): e0220025.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0220025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6650144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31335889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chung%20H,%20Fierro%20A,%20Pessoa-Mahana%20CD.%20Cannabidiol%20binding%20and%20negative%20allosteric%20modulation%20at%20the%20cannabinoid%20type%201%20receptor%20in%20the%20presence%20of%20delta-9-tetrahydrocannabinol:%20an%20in%20silico%20study.%20PLoS%20ONE.%202019;14(7):%20e0220025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Gillham SH, et al. Does a broad-spectrum cannabidiol supplement improve performance in a 10-min cycle ergometer performance-test? Eur J Sport Sci. 2024;24(7):870–7.
</cite> [<a href="https://doi.org/10.1002/ejsc.12116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11236031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38956805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gillham%20SH,%20et%20al.%20Does%20a%20broad-spectrum%20cannabidiol%20supplement%20improve%20performance%20in%20a%2010-min%20cycle%20ergometer%20performance-test?%20Eur%20J%20Sport%20Sci.%202024;24(7):870%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Cheung CP, et al. Cannabis containing THC impairs 20-min cycling time trial performance irrespective of the method of inhalation. J Appl Physiol (1985). 2024;136(3):583–91.
</cite> [<a href="https://doi.org/10.1152/japplphysiol.00757.2023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38299223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheung%20CP,%20et%20al.%20Cannabis%20containing%20THC%20impairs%2020-min%20cycling%20time%20trial%20performance%20irrespective%20of%20the%20method%20of%20inhalation.%20J%20Appl%20Physiol%20(1985).%202024;136(3):583%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Flores VA, et al. Effects of oral cannabidiol on health and fitness in healthy adults: an 8-week randomized trial. Nutrients. 2023. 10.3390/nu15122664.
</cite> [<a href="https://doi.org/10.3390/nu15122664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10301202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37375567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Flores%20VA,%20et%20al.%20Effects%20of%20oral%20cannabidiol%20on%20health%20and%20fitness%20in%20healthy%20adults:%20an%208-week%20randomized%20trial.%20Nutrients.%202023.%2010.3390/nu15122664." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Burke LM, et al. Adaptation to a low carbohydrate high fat diet is rapid but impairs endurance exercise metabolism and performance despite enhanced glycogen availability. J Physiol. 2020. 10.1113/JP280221.
</cite> [<a href="https://doi.org/10.1113/JP280221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7891450/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32697366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burke%20LM,%20et%20al.%20Adaptation%20to%20a%20low%20carbohydrate%20high%20fat%20diet%20is%20rapid%20but%20impairs%20endurance%20exercise%20metabolism%20and%20performance%20despite%20enhanced%20glycogen%20availability.%20J%20Physiol.%202020.%2010.1113/JP280221." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983;55(2):628–34.
</cite> [<a href="https://doi.org/10.1152/jappl.1983.55.2.628" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6618956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frayn%20KN.%20Calculation%20of%20substrate%20oxidation%20rates%20in%20vivo%20from%20gaseous%20exchange.%20J%20Appl%20Physiol%20Respir%20Environ%20Exerc%20Physiol.%201983;55(2):628%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Emhoff CW, Messonnier LA. Concepts of lactate metabolic clearance rate and lactate clamp for metabolic inquiry: a mini-review. Nutrients. 2023;15(14).</cite> [<a href="https://doi.org/10.3390/nu15143213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10385598/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37513631/" class="usa-link">PubMed</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Cavuoto P, et al. Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrinol. 2007;267(1):63–9.
</cite> [<a href="https://doi.org/10.1016/j.mce.2006.12.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17270342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cavuoto%20P,%20et%20al.%20Effects%20of%20cannabinoid%20receptors%20on%20skeletal%20muscle%20oxidative%20pathways.%20Mol%20Cell%20Endocrinol.%202007;267(1):63%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Kuo T, et al. Regulation of glucose homeostasis by glucocorticoids. Adv Exp Med Biol. 2015;872:99–126.
</cite> [<a href="https://doi.org/10.1007/978-1-4939-2895-8_5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6185996/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26215992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuo%20T,%20et%20al.%20Regulation%20of%20glucose%20homeostasis%20by%20glucocorticoids.%20Adv%20Exp%20Med%20Biol.%202015;872:99%E2%80%93126." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Vincent S, et al. Plasma glucose, insulin and catecholamine responses to a Wingate test in physically active women and men. Eur J Appl Physiol. 2004;91(1):15–21.
</cite> [<a href="https://doi.org/10.1007/s00421-003-0957-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14551777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vincent%20S,%20et%20al.%20Plasma%20glucose,%20insulin%20and%20catecholamine%20responses%20to%20a%20Wingate%20test%20in%20physically%20active%20women%20and%20men.%20Eur%20J%20Appl%20Physiol.%202004;91(1):15%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Zuardi AW, Guimarães FS, Moreira AC. Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz J Med Biol Res. 1993;26(2):213–7.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8257923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zuardi%20AW,%20Guimar%C3%A3es%20FS,%20Moreira%20AC.%20Effect%20of%20cannabidiol%20on%20plasma%20prolactin,%20growth%20hormone%20and%20cortisol%20in%20human%20volunteers.%20Braz%20J%20Med%20Biol%20Res.%201993;26(2):213%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Townsend R, et al. Low dose daily CBD beverage consumption for eight weeks does not improve physical and mental health measures in healthy individuals: a randomized clinical trial. Brain Behav Immunity Integrat. 2024;7: 100079.</cite> [<a href="https://scholar.google.com/scholar_lookup?Townsend%20R,%20et%20al.%20Low%20dose%20daily%20CBD%20beverage%20consumption%20for%20eight%20weeks%20does%20not%20improve%20physical%20and%20mental%20health%20measures%20in%20healthy%20individuals:%20a%20randomized%20clinical%20trial.%20Brain%20Behav%20Immunity%20Integrat.%202024;7:%20100079." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Liebling JP, et al. An analysis of over-the-counter cannabidiol products in the United Kingdom. Cannabis Cannabinoid Res. 2022;7(2):207–13.
</cite> [<a href="https://doi.org/10.1089/can.2019.0078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9070743/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33998849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liebling%20JP,%20et%20al.%20An%20analysis%20of%20over-the-counter%20cannabidiol%20products%20in%20the%20United%20Kingdom.%20Cannabis%20Cannabinoid%20Res.%202022;7(2):207%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Gurley BJ, et al. Content versus label claims in cannabidiol (CBD)-containing products obtained from commercial outlets in the state of Mississippi. J Diet Suppl. 2020;17(5):599–607.
</cite> [<a href="https://doi.org/10.1080/19390211.2020.1766634" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32431186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gurley%20BJ,%20et%20al.%20Content%20versus%20label%20claims%20in%20cannabidiol%20(CBD)-containing%20products%20obtained%20from%20commercial%20outlets%20in%20the%20state%20of%20Mississippi.%20J%20Diet%20Suppl.%202020;17(5):599%E2%80%93607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>World-Anti-Doping-Agency. World Anti-Doping Code 2021. 2021. Available from: <a href="https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.wada-ama.org/sites/default/files/resources/files/2021_wada_code.pdf</a>.</cite>
</li>
<li id="CR83">
<span class="label">83.</span><cite>Isenmann E, et al. Short-term repeated oral intake of low dose cannabidiol: effects on liver enzyme activity and creatinine concentration during intense exercise. Arch Toxicol. 2025;99(2):815–24.
</cite> [<a href="https://doi.org/10.1007/s00204-024-03904-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39630203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Isenmann%20E,%20et%20al.%20Short-term%20repeated%20oral%20intake%20of%20low%20dose%20cannabidiol:%20effects%20on%20liver%20enzyme%20activity%20and%20creatinine%20concentration%20during%20intense%20exercise.%20Arch%20Toxicol.%202025;99(2):815%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Özgünen K, et al. The relationship between cardiac damage biomarkers and heart rate variability following 60 min of running. Clin Auton Res. 2022;32(4):249–60.
</cite> [<a href="https://doi.org/10.1007/s10286-022-00878-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35877021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C3%96zg%C3%BCnen%20K,%20et%20al.%20The%20relationship%20between%20cardiac%20damage%20biomarkers%20and%20heart%20rate%20variability%20following%2060%20min%20of%20running.%20Clin%20Auton%20Res.%202022;32(4):249%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Bakar Y, et al. Effect of manual lymph drainage on removal of blood lactate after submaximal exercise. J Phys Ther Sci. 2015;27(11):3387–91.
</cite> [<a href="https://doi.org/10.1589/jpts.27.3387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4681911/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26696704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bakar%20Y,%20et%20al.%20Effect%20of%20manual%20lymph%20drainage%20on%20removal%20of%20blood%20lactate%20after%20submaximal%20exercise.%20J%20Phys%20Ther%20Sci.%202015;27(11):3387%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Ribeiro FM, et al. Is there an exercise-intensity threshold capable of avoiding the leaky gut? Front Nutr. 2021;8.</cite> [<a href="https://doi.org/10.3389/fnut.2021.627289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7982409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33763441/" class="usa-link">PubMed</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Vargas N, Marino F. Heat stress, gastrointestinal permeability and interleukin-6 signaling - implications for exercise performance and fatigue. Temperature (Austin). 2016;3(2):240–51.
</cite> [<a href="https://doi.org/10.1080/23328940.2016.1179380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4964994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27857954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vargas%20N,%20Marino%20F.%20Heat%20stress,%20gastrointestinal%20permeability%20and%20interleukin-6%20signaling%20-%20implications%20for%20exercise%20performance%20and%20fatigue.%20Temperature%20(Austin).%202016;3(2):240%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Wallett AM, et al. Running at increasing intensities in the heat induces transient gut perturbations. Int J Sports Physiol Perform. 2021;16(5):704–10.
</cite> [<a href="https://doi.org/10.1123/ijspp.2019-0973" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33361496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wallett%20AM,%20et%20al.%20Running%20at%20increasing%20intensities%20in%20the%20heat%20induces%20transient%20gut%20perturbations.%20Int%20J%20Sports%20Physiol%20Perform.%202021;16(5):704%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Bischoff SC, et al. Intestinal permeability–a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.
</cite> [<a href="https://doi.org/10.1186/s12876-014-0189-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4253991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25407511/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bischoff%20SC,%20et%20al.%20Intestinal%20permeability%E2%80%93a%20new%20target%20for%20disease%20prevention%20and%20therapy.%20BMC%20Gastroenterol.%202014;14:189." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Souza JDR, et al. Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022). Pharmaceutics. 2022. 10.3390/pharmaceutics14122598.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14122598" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9782576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36559092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Souza%20JDR,%20et%20al.%20Adverse%20effects%20of%20oral%20cannabidiol:%20an%20updated%20systematic%20review%20of%20randomized%20controlled%20trials%20(2020%E2%80%932022).%20Pharmaceutics.%202022.%2010.3390/pharmaceutics14122598." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Dos Santos RG, et al. Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials. Expert Opin Drug Metab Toxicol. 2020;16(6):517–26.
</cite> [<a href="https://doi.org/10.1080/17425255.2020.1754793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32271618/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dos%20Santos%20RG,%20et%20al.%20Serious%20adverse%20effects%20of%20cannabidiol%20(CBD):%20a%20review%20of%20randomized%20controlled%20trials.%20Expert%20Opin%20Drug%20Metab%20Toxicol.%202020;16(6):517%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12370602/bin/40798_2025_895_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (357.9KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The deidentified participant data are available from Ms Ayshe Sahinovic upon reasonable request (ayshe.sahinovic@sydney.edu.au).</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Sports Medicine - Open are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40798-025-00895-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40798_2025_Article_895.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370602/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370602/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370602%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370602/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370602/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370602/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40839290/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370602/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40839290/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370602/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370602/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="eIwAx0T4komD3alKk80CO8DqPej4NwnKCFhIsEltq7KvklQnThxkkGvvEDC4TAcB">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
